Browse by Current Cardiff authors

Courtier, Nicholas, Gambling, Tina, Barrett-Lee, Peter, Oliver, Theo and Mason, Malcolm 2019. The volume of liver irradiated during modern free-breathing breast radiotherapy: implications for theory and practice. Radiography , -. 10.1016/j.radi.2018.12.003 Item availability restricted.

Parker, Christopher C, James, Nicholas D, Brawley, Christopher D, Clarke, Noel W, Hoyle, Alex P, Ali, Adnan, Ritchie, Alastair W S, Attard, Gerhardt, Chowdhury, Simon, Cross, William, Dearnaley, David P, Gillessen, Silke, Gilson, Clare, Jones, Robert J, Langley, Ruth E, Malik, Zafar I, Mason, Malcolm D, Matheson, David, Millman, Robin, Russell, J Martin, Thalmann, George N, Amos, Claire L, Alonzi, Roberto, Bahl, Amit, Birtle, Alison, Din, Omar, Douis, Hassan, Eswar, Chinnamani, Gale, Joanna, Gannon, Melissa R, Jonnada, Sai, Khaksar, Sara, Lester, Jason F, O'Sullivan, Joe M, Parikh, Omi A, Pedley, Ian D, Pudney, Delia M, Sheehan, Denise J, Srihari, Narayanan Nair, Tran, Anna T H, Parmar, Mahesh K B and Sydes, Matthew R 2018. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Lancet 392 (10162) , pp. 2353-2366. 10.1016/S0140-6736(18)32486-3

Lam, Thomas B.L., MacLennan, Steven, Plass, Karin, Willemse, Peter-Paul M., Mason, Malcolm D., Cornford, Philip, Donaldson, James, Davis, Niall F., Dell'Oglio, Paolo, Fankhauser, Christian, Grivas, Nikos, Ingels, Alexandre, Lardas, Michael, Liew, Matthew, Pang, Karl H., Paterson, Catherine, Omar, Muhammad I., Zattoni, Fabio, Buddingh, Karel T., Van den Broeck, Thomas, Cumberbatch, Marcus G., Fossati, Nicola, Gross, Tobias, Moris, Lisa, Schoots, Ivo G., van den Bergh, Roderick C.N., Briers, Erik, Fanti, Stefano, De Santis, Maria, Gillessen, Silke, Grummet, Jeremy P., Henry, Ann M., van der Poel, Henk G., van der Kwast, Theodorus H., Rouvière, Olivier, Tilki, Derya, Wiegel, Thomas, N'Dow, James, Van Poppel, Hendrik and Mottet, Nicolas 2018. Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer. European Urology , -. 10.1016/j.eururo.2018.11.009 Item availability restricted.

Donnelly, David W, Donnelly, Conan, Kearney, Therese, Weller, David, Sharp, Linda, Downing, Amy, Wilding, Sarah, Wright, Penny, Kind, Paul, Catto, James W F, Cross, William R, Mason, Malcolm, McCaughan, Eilis, Wagland, Richard, Watson, Eila, Mottram, Rebecca, Allen, Majorie, Butcher, Hugh, Hounsome, Luke, Selby, Peter, Huws, Dyfed, Brewster, David H, McNair, Emma, Rivas, Carol, Nayoan, Johana, Horton, Mike, Matheson, Lauren, Glaser, Adam W and Gavin, Anna 2018. Urinary, bowel and sexual health in older men from Northern Ireland. BJU International 122 (5) , pp. 845-857. 10.1111/bju.14182 Item availability restricted.

Elwood, Peter, Pickering, Janet E., Morgan, Gareth, Galante, Julieta, Weightman, Alison L., Morris, Delyth, Longley, Marcus, Mason, Malcolm, Adams, Richard, Dolwani, Sunil, Chia W. K., John and Lanas, Angel 2018. Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients? PLoS ONE 13 (9) , e0203957. 10.1371/journal.pone.0203957

Van den Broeck, Thomas, van den Bergh, Roderick C.N., Arfi, Nicolas, Gross, Tobias, Moris, Lisa, Briers, Erik, Cumberbatch, Marcus, De Santis, Maria, Tilki, Derya, Fanti, Stefano, Fossati, Nicola, Gillessen, Silke, Grummet, Jeremy P., Henry, Ann M., Lardas, Michael, Liew, Matthew, Rouvière, Olivier, Pecanka, Jakub, Mason, Malcolm D., Schoots, Ivo G., van Der Kwast, Theo H., van Der Poel, Henk G., Wiegel, Thomas, Willemse, Peter-Paul M., Yuan, Yuhong, Lam, Thomas B., Cornford, Philip and Mottet, Nicolas 2018. Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review. European Urology , -. 10.1016/j.eururo.2018.10.011 Item availability restricted.

Courtier, Nicholas, Gambling, Tina, Barrett-Lee, Peter and Mason, Malcolm D 2018. Soluble interleukin-6 receptor mediated fatigue highlights immunological heterogeneity of patients with early breast cancer who undergo radiation therapy. Advances in Radiation Oncology 3 (4) , pp. 552-558. 10.1016/j.adro.2018.05.007

Lindsay, Colin R, Shaw, Emily C, Blackhall, Fiona, Blyth, Kevin G, Brenton, James D, Chaturvedi, Anshuman, Clarke, Noel, Dick, Craig, Evans, Thomas R J, Hall, Geoff, Hanby, Andrew M, Harrison, David J, Johnston, Stephen R D, Mason, Malcolm D, Morton, Dion, Newton-Bishop, Julia, Nicholson, Andrew G, Oien, Karin A, Popat, Sanjay, Rassl, Doris, Sharpe, Rowena, Taniere, Phillipe, Walker, Ian, Wallace, William A, West, Nicholas P, Butler, Rachel, Gonzalez de Castro, David, Griffiths, Mike and Johnson, Peter W M 2018. Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme. ESMO Open 3 (6) , e000408. 10.1136/esmoopen-2018-000408

van der Poel, Henk G., van den Bergh, Roderick C.N., Briers, Erik, Cornford, Philip, Govorov, Alex, Henry, Ann M., Lam, Thomas B., Mason, Malcolm David, Rouvière, Olivier, De Santis, Maria, Willemse, Peter-Paul M., van Poppel, Hendrik and Mottet, Nicolas 2018. Focal therapy in primary localised prostate cancer: The European Association of Urology position in 2018. European Urology 74 (1) , pp. 84-91. 10.1016/j.eururo.2018.01.001

Jenkins, V., Payne, H., Mason, Malcolm, May, S., Matthews, L. and Catt, S. 2018. EXTREQOL identifies ongoing challenges in maximising quality of survival in men with Metastatic Castrate-resistant Prostate Cancer. Clinical Oncology 30 (6) , pp. 331-333. 10.1016/j.clon.2018.02.001

Donovan, Jenny L., Young, Grace J., Walsh, Eleanor I., Metcalfe, Chris, Lane, J. Athene, Martin, Richard M., Tazewell, Marta K., Davis, Michael, Peters, Tim J., Turner, Emma L., Mills, Nicola, Khazragui, Hanan, Khera, Tarnjit K., Neal, David E., Hamdy, Freddie C., Bollina, Prasad, Catto, James, Doble, Andrew, Doherty, Alan, Gillatt, David, Gnanapragasam, Vincent, Holding, Peter, Hughes, Owen, Kockelbergh, Roger, Kynaston, Howard, Mason, Malcolm, Oxley, Jon, Paul, Alan, Paez, Edgar, Rosario, Derek J., Rowe, Edward and Staffurth, John 2018. A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial. Journal of Clinical Epidemiology 96 , pp. 35-46. 10.1016/j.jclinepi.2017.12.019

Sydes, Matthew R, Spears, Melissa R, Mason, Malcolm, Clarke, Noel W, Dearnaley, David P, de Bono, Johann S, Attard, Gert, Chowdhury, Simon, Cross, Bill, Gillessen, Silke, Malik, Zaf, Jones, Rob, Parker, Chris, Ritchie, Alastair WS, Russell, J Martin, Millman, Robin, Matheson, David, Amos, Claire, Gilson, Clare, Birtle, Alison, Brock, Susannah, Capaldi, Lisa, Chakraborti, Prabir, Choudhury, Ananya, Evans, Linda, Ford, Daniel, Gale, Joanna, Gibbs, Stephanie, Gilbert, Duncan, Hughes, Robert, McLaren, Duncan, Lester, Jason, Nikapota, Ashok, O'Sullivan, Joe, Parikh, Omi, Peedell, Clive, Protheroe, Andrew, Rudman, Sarah M, Shaffer, Richard, Sheehan, Denise, Simms, Matthew, Srihari, Narayanan, Strebel, Räto, Sundar, Santhanam, Tolan, Shaun, Tsang, David, Varughese, Mohini, Wagstaff, John, Parmar, Mahesh KB and James, Nicholas D 2018. Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol. Annals of Oncology 2 (1) 10.1093/annonc/mdy072

Vale, C L, Fisher, D J, White, I R, Carpenter, J R, Burdett, S, Clarke, N W, Fizazi, K, Gravis, G, James, N D, Mason, Malcolm, Parmar, M K B, Rydzewska, L H, Sweeney, C J, Spears, M R, Sydes, M R and Tierney, J F 2018. What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis. Annals of Oncology 29 (5) , pp. 1249-1257. 10.1093/annonc/mdy071 Item availability restricted.

Langley, R.E. and Mason, Malcolm 2017. Multi-arm clinical trials - teams within teams. Clinical Oncology 29 (12) , pp. 787-788. 10.1016/j.clon.2017.10.001

Aggarwal, Ajay, Lewis, Daniel, Sujenthiran, Arunan, Charman, Susan C., Sullivan, Richard, Payne, Heather, Mason, Malcolm and van der Meulen, Jan 2017. Hospital quality factors influencing the mobility of patients for radical prostate cancer radiation therapy: a national population-based study. International Journal of Radiation Oncology*Biology*Physics 99 (5) , pp. 1261-1270. 10.1016/j.ijrobp.2017.08.018

Aggarwal, Ajay, Lewis, Daniel, Mason, Malcolm, Purushotham, Arnie, Sullivan, Richard and van der Meulen, Jan 2017. Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based study. The Lancet Oncology 18 (11) , pp. 1445-1453. 10.1016/S1470-2045(17)30572-7

Walker, Steven M., Knight, Laura A., McCavigan, Andrena M., Logan, Gemma E., Berge, Viktor, Sherif, Amir, Pandha, Hardev, Warren, Anne Y., Davidson, Catherine, Uprichard, Adam, Blayney, Jaine K., Price, Bethanie, Jellema, Gera L., Steele, Christopher J., Svindland, Aud, McDade, Simon S., Eden, Christopher G., Foster, Chris, Mills, Ian G., Neal, David E., Mason, Malcolm David, Kay, Elaine W., Waugh, David J., Harkin, D. Paul, Watson, R. William, Clarke, Noel W. and Kennedy, Richard D. 2017. Molecular subgroup of primary prostate cancer presenting with metastatic biology. European Urology 72 (4) , pp. 509-518. 10.1016/j.eururo.2017.03.027

Rydzewska, Larysa H.M., Burdett, Sarah, Vale, Claire L., Clarke, Noel W., Fizazi, Karim, Kheoh, Thian, Mason, Malcolm D., Miladinovic, Branko, James, Nicholas D., Parmar, Mahesh K.B., Spears, Melissa R., Sweeney, Christopher J., Sydes, Matthew R., Tran, NamPhuong and Tierney, Jayne F. 2017. Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis. European Journal of Cancer 84 , pp. 88-101. 10.1016/j.ejca.2017.07.003

Sobkowicz, Anna D., Sanders, Andrew J., Mason, Malcolm D. and Jiang, Wen G. 2017. Potential implication of Paxillin in cancer establishment within the bone environment. Anticancer Research 37 (8) , pp. 4255-4268. 10.21873/anticanres.11818

Fossati, Nicola, Willemse, Peter-Paul M., Van den Broeck, Thomas, van den Bergh, Roderick C. N., Yuan, Cathy Yuhong, Briers, Erik, Bellmunt, Joaquim, Bolla, Michel, Cornford, Philip, De Santis, Maria, MacPepple, Ekelechi, Henry, Ann M., Mason, Malcolm D., Matveev, Vsevolod B., van der Poel, Henk G., van der Kwast, Theo H., Rouviere, Olivier, Schoots, Ivo G., Wiegel, Thomas, Lam, Thomas B., Mottet, Nicolas and Joniau, Steven 2017. The benefits and harms of different extents of lymph node dissection during radical prostatectomy for prostate cancer: a systematic review. European Urology 72 (1) , pp. 84-109. 10.1016/j.eururo.2016.12.003

Mason, Malcolm, Richaud, Pierre, Bosnyak, Zsolt, Malmberg, Anders and Neijber, Anders 2017. Degarelix versus Goserelin plus Bicalutamide in the short-term relief of lower urinary tract symptoms in prostate cancer patients: results of a pooled analysis. LUTS: Lower Urinary Tract Symptoms 9 (2) , pp. 82-88. 10.1111/luts.12114

Mason, Malcolm D., Clarke, Noel W., James, Nicholas D., Dearnaley, David P., Spears, Melissa R., Ritchie, Alastair W. S., Attard, Gerhardt, Cross, William, Jones, Rob J., Parker, Christopher C., Russell, J. Martin, Thalmann, George N., Schiavone, Francesca, Cassoly, Estelle, Matheson, David, Millman, Robin, Rentsch, Cyrill A., Barber, Jim, Gilson, Clare, Ibrahim, Azman, Logue, John, Lydon, Anna, Nikapota, Ashok D., O'Sullivan, Joe M., Porfiri, Emilio, Protheroe, Andrew, Srihari, Narayanan Nair, Tsang, David, Wagstaff, John, Wallace, Jan, Walmsley, Catherine, Parmar, Mahesh K. B. and Sydes, Matthew R. 2017. Adding celecoxib with or without Zoledronic acid for hormone-naive prostate cancer: Long-term survival results from an adaptive, multiarm, multistage, platform, randomized controlled trial. Journal of Clinical Oncology 35 (14) , pp. 1530-1541. 10.1200/JCO.2016.69.0677

Sun, Ping-Hui, Chen, Gang, Mason, Malcolm, Jiang, Wen and Ye, Lin 2017. Dual roles of protein tyrosine phosphatase kappa in coordinating angiogenesis induced by pro-angiogenic factors. International Journal of Oncology 50 (4) , pp. 1127-1135. 10.3892/ijo.2017.3884

Mottet, Nicolas, Bellmunt, Joaquim, Bolla, Michel, Briers, Erik, Cumberbatch, Marcus G., De Santis, Maria, Fossati, Nicola, Gross, Tobias, Henry, Ann M., Joniau, Steven, Lam, Thomas B., Mason, Malcolm David, Matveev, Vsevolod B., Moldovan, Paul C., van den Bergh, Roderick C.N., Van den Broeck, Thomas, van der Poel, Henk G., van der Kwast, Theo H., Rouvière, Olivier, Schoots, Ivo G., Wiegel, Thomas and Cornford, Philip 2017. EAU-ESTRO-SIOG guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent. European Urology 71 (4) , pp. 618-629. 10.1016/j.eururo.2016.08.003

Lane, Athene, Metcalfe, Chris, Young, Grace J., Peters, Tim J., Blazeby, Jane, Avery, Kerry N. L., Dedman, Daniel, Down, Liz, Mason, Malcolm David, Neal, David E., Hamdy, Freddie C. and Donovan, Jenny L. 2016. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life. British Journal of Urology International 118 (6) , pp. 869-879. 10.1111/bju.13582

Gnanapragasam, VJ, Hori, S, Johnston, T, Smith, D, Muir, K, Alonzi, R, Winkler, M, Warren, A, Staffurth, John, Khoo, V, Tree, A, Macneill, A, McMenemin, R, Mason, Malcolm, Cathcart, P, de Souza, N, Sooriakumaran, P, Weston, R, Wylie, J, Hall, E, Lane, A, Cross, W, Syndikus, I and Koupparis, A 2016. Clinical management and research priorities for high-risk prostate cancer in the UK: Meeting report of a multidisciplinary panel in conjunction with the NCRI Prostate Cancer Clinical Studies Localised Subgroup. Journal of Clinical Urology 9 (6) , pp. 369-379. 10.1177/2051415816651362

Donovan, Jenny L., Hamdy, Freddie C., Lane, J. Athene, Mason, Malcolm David, Metcalfe, Chris, Walsh, Eleanor, Blazeby, Jane M., Peters, Tim J., Holding, Peter, Bonnington, Susan, Lennon, Teresa, Bradshaw, Lynne, Cooper, Deborah, Herbert, Phillipa, Howson, Joanne, Jones, Amanda, Lyons, Norma, Salter, Elizabeth, Thompson, Pauline, Tidball, Sarah, Blaikie, Jan, Gray, Catherine, Bollina, Prasad, Catto, James, Doble, Andrew, Doherty, Alan, Gillatt, David, Kockelbergh, Roger, Kynaston, Howard, Paul, Alan, Powell, Philip, Prescott, Stephen, Rosario, Derek J., Rowe, Edward, Davis, Michael, Turner, Emma L., Martin, Richard M. and Neal, David E. 2016. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer. New England Journal of Medicine 375 (15) , pp. 1425-1437. 10.1056/NEJMoa1606221

Johnston, Thomas J., Shaw, Greg L., Lamb, Alastair D., Parashar, Deepak, Greenberg, David, Xiong, Tengbin, Edwards, Alison L., Gnanapragasam, Vincent, Holding, Peter, Herbert, Phillipa, Davis, Michael, Mizielinsk, Elizabeth, Lane, J. Athene, Oxley, Jon, Robinson, Mary, Mason, Malcolm, Staffurth, John, Bollina, Prasad, Catto, James, Doble, Andrew, Doherty, Alan, Gillatt, David, Kockelbergh, Roger, Kynaston, Howard, Prescott, Steve, Paul, Alan, Powell, Philip, Rosario, Derek, Rowe, Edward, Donovan, Jenny L., Hamdy, Freddie C. and Neal, David E. 2016. Mortality among men with advanced prostate cancer excluded from the ProtecT trial. European Urology 71 (3) , pp. 381-388. 10.1016/j.eururo.2016.09.040

Mason, Malcolm David, Moore, R., Jones, G., Lewis, G., Donovan, J.L., Neal, D.E., Hamdy, F.C., Lane, J.A., Staffurth, J.N., Bonnington, Sue, Bradshaw, Lynne, Cooper, Debbie, Elliott, Emma, Herbert, Pippa, Holding, Peter, Howson, Joanne, Jones, Mandy, Lennon, Teresa, Lyons, Norma, Moody, Hilary, Plumb, Claire, O'Sullivan, Tricia, Salter, Liz, Tidball, Sarah, Thompson, Pauline, Adam, Tonia, Askew, Sarah, Atkinson, Sharon, Baynes, Tim, Blaikie, Jan, Brain, Carole, Breen, Viv, Brunt, Sarah, Bryne, Sean, Bythem, Jo, Clarke, Jenny, Cloete, Jenny, Dark, Susan, Davis, Gill, De La Rue, Rachael, Denizot, Jane, Dewhurst, Elspeth, Dimes, Anna, Dixon, Nicola, Ebbs, Penny, Emmerson, Ingrid, Ferguson, Jill, Gadd, Ali, Geoghegan, Lisa, Grant, Alison, Grant, Collette, Gray, Catherine, Godfrey, Rosemary, Goodwin, Louise, Hall, Susie, Hart, Liz, Harvey, Andrew, Hoult, Chloe, Hawkins, Sarah, Holling, Sharon, Innes, Alastair, Kilner, Sue, Marshall, Fiona, Mellen, Louise, Moore, Andrea, Napier, Sally, Needham, Julie, Pearse, Kevin, Pisa, Anna, Rees, Mark, Richards, Elliw, Robson, Lindsay, Roxburgh, Janet, Samuel, Nikki, Sharkey, Irene, Slater, Michael, Smith, Donna, Taggart, Pippa, Taylor, Helen, Taylor, Vicky, Thomas, Ayesha, Tomkies, Briony, Trewick, Nicola, Ward, Claire, Walker, Christy, Williams, Ayesha, Woodhouse, Colin, Wyber, Elizabeth, Aning, Jonathan, Bollina, Prasad, Catto, Jim, Doble, Andrew, Doherty, Alan, Durkan, Garett, Gillatt, David, Hughes, Owen, Kocklebergh, Roger, Kouparis, Anthony, Kynaston, Howard, Leung, Hing, Mariappan, Param, McNeill, Alan, Paez, Edgar, Paul, Alan, Persad, Raj, Powell, Philip, Prescott, Stephen, Rosario, Derek, Rowe, Edward, Schwaibold, Hartwig, Tulloch, David, Wallace, Mike, Bahl, Amit, Benson, Richard, Beresford, Mark, Ferguson, Catherine, Graham, John, Herbert, Chris, Howard, Graham, James, Nick, Law, Alastair, Loughrey, Carmel, Mason, Malcolm, McClaren, Duncan, Patterson, Helen, Pedley, Ian, Robinson, Angus, Russell, Simon, Staffurth, John, Symonds, Paul, Thanvi, Narottam, Vasanthan, Subramaniam, Wilson, Paula, Appleby, Helen, Ash, Dominic, Aston, Dean, Bolton, Steven, Chalmers, Graham, Conway, John, Early, Nick, Geater, Tony, Goddall, Lynda, Heymann, Claire, Hicks, Deborah, Jones, Liza, Lamb, Susan, Lambert, Geoff, Lawrence, Gill, Lewis, Geraint, Lilley, John, MacLeod, Aileen, Massey, Pauline, McQueen, Alison, Moore, Rollo, Penketh, Lynda, Potterton, Janet, Roberts, Neil, Showler, Helen, Slade, Stephen, Steele, Alasdair, Swinscoe, James, Tiffany, Marie, Townley, John, Treeby, Jo, Wilkinson, Joyce, Williams, Lorraine, Wills, Lucy, Woodley, Owain, Yarrow, Sue, Bhattarai, Selina, Deshmukh, Neeta, Dormer, John, Fernando, Malee, Goepel, John, Griffiths, David, Grigor, Ken, Mayer, Nick, Oxley, Jon, Robinson, Mary, Varma, Murali, Warren, Anne, Brindle, Lucy, Davis, Michael, Dedman, Dan, Down, Elizabeth, Khazragui, Hanan, Metcalfe, Chris, Noble, Sian, Peters, Tim, Taylor, Hilary, Turner, Emma, Wade, Julia, Walsh, Eleanor, Baker, Susan, Bellis-Sheldon, Elizabeth, Bougard, Chantal, Bowtell, Joanne, Brewer, Catherine, Burton, Chris, Charlton, Jennie, Christoforou, Nicholas, Clark, Rebecca, Coull, Susan, Croker, Christine, Currer, Rosemary, Daisey, Claire, Delaney, Gill, Donohue, Rose, Drew, Jane, Farmer, Rebecca, Fry, Susan, Haddow, Jean, Hale, Alex, Halpin, Susan, Harris, Belle, Hattrick, Barbara, Holmes, Sharon, Hunt, Helen, Jackson, Vicky, Johnson, Donna, Le Butt, Mandy, Leworthy, Jo, Liddiatt, Tanya, Martin, Alex, Mauree, Jainee, Moore, Susan, Moulam, Gill, Mutch, Jackie, Parker, Kathleen, Pawsey, Christopher, Purdie, Michelle, Robson, Teresa, Smith, Lynne, Stenton, Carole, Steuart-Feilding, Tom, Sully, Chris, Sutton, Caroline, Torrington, Carol, Wilkins, Zoe, Williams, Sharon, Wilson, Andrea, Grant, Adrian, Roberts, Ian, Ashby, Deborah, Cowan, Richard, Fayers, Peter, Mellon, Killian, N'Dow, James, O'Brien, Tim, Sokhal, Michael, Baum, Michael, Adolfson, Jan, Albertsen, Peter, Dearnaley, David, Schroeder, Fritz, Roberts, Tracy and Zietman, Anthony 2016. Radiotherapy for prostate cancer: is it 'what you do' or 'the way that you do it'? a UK perspective on technique and quality assurance. Clinical Oncology 28 (9) , e92-e100. 10.1016/j.clon.2016.05.011

Tanguay, J. S., Catlow, Charles Richard A., Smith, C., Barber, J., Staffurth, John Nicholas, Kumar, S., Palaniappan, N., Button, M. and Mason, Malcolm David 2016. High risk of neutropenia for hormone-naive prostate cancer patients receiving STAMPEDE-style upfront Docetaxel chemotherapy in usual clinical practice. Clinical Oncology 28 (9) , p. 611. 10.1016/j.clon.2016.03.006

South, Annabelle, Parulekar, Wendy R., Sydes, Matthew R., Chen, Bingshu E., Parmar, Mahesh K., Clarke, Noel, Warde, Padraig and Mason, Malcolm 2016. Estimating the impact of randomised control trial results on clinical practice: results from a survey and modelling study of androgen deprivation therapy plus radiotherapy for locally advanced prostate cancer. European Urology Focus 2 (3) , pp. 276-283. 10.1016/j.euf.2015.11.004

James, Nicholas D., Sydes, Matthew R., Clarke, Noel W., Mason, Malcolm D. and Parmar, Mahesh K. B. 2016. Untitled reply. The Lancet 388 (10041) , pp. 235-236.

Welton, Joanne Louise, Brennan, Paul, Gurney, Mark, Webber, Jason Paul, Spary, Lisa Kate, Gil Carton, David, Falcón-Pérez, Juan Manuel, Walton, Sean Peter, Mason, Malcolm David, Tabi, Zsuzsanna and Clayton, Aled 2016. Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array. Journal of Extracellular Vesicles 5 , 31209. 10.3402/jev.v5.31209

James, Nicholas D., Sydes, Matthew R., Clarke, Noel W., Mason, Malcolm David, Dearnaley, David P., Spears, Melissa R., Ritchie, Alastair W. S., Parker, Christopher C., Russell, J. Martin, Attard, Gerhardt, de Bono, Johann, Cross, William, Jones, Rob J., Thalmann, George, Amos, Claire, Matheson, David, Millman, Robin, Alzouebi, Mymoona, Beesley, Sharon, Birtle, Alison J., Brock, Susannah, Cathomas, Richard, Chakraborti, Prabir, Chowdhury, Simon, Cook, Audrey, Elliott, Tony, Gale, Joanna, Gibbs, Stephanie, Graham, John D., Hetherington, John, Hughes, Robert, Laing, Robert, McKinna, Fiona, McLaren, Duncan B., O'Sullivan, Joe M., Parikh, Omi, Peedell, Clive, Protheroe, Andrew, Robinson, Angus J., Srihari, Narayanan, Srinivasan, Rajaguru, Staffurth, John, Sundar, Santhanam, Tolan, Shaun, Tsang, David, Wagstaff, John and Parmar, Mahesh K. B. 2016. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. The Lancet 387 (10024) , pp. 1163-1177. 10.1016/S0140-6736(15)01037-5

James, Nicholas D., Spears, Melissa R., Clarke, Noel W., Dearnaley, David P., Mason, Malcolm David, Parker, Christopher C., Ritchie, Alastair W. C., Russell, J. Martin, Schiavone, Francesca, Attard, Gerhardt, De Bono, Johann S, Birtle, Alison, Engleler, Daniel S., Elliott, Tony, Matheson, David, O’Sullivan, Joe, Pudney, Delia, Srihari, Narayanan, Wallace, Jan, Barber, Jim, Syndikus, Isabel, Parmar, Mahesh K. B. and Sydes, Matthew R. 2016. Failure-free survival and radiotherapy in patients with newly diagnosed nonmetastatic prostate cancer data from patients in the control arm of the STAMPEDE trial. JAMA Oncology 2 (3) , pp. 348-357. 10.1001/jamaoncol.2015.4350

Satherley, Lucy, Sun, P. H., Ke, Ji, Mason, Malcolm David, Hargest, Rachel, Jiang, Wen Guo and Ye, Lin 2016. Prostate Apoptosis Response-4 (PAR4) suppresses growth and invasion of breast cancer cells and is positively associated with patient survival. Anticancer Research 36 (3) , pp. 1227-1236.

Owen, Sioned, Sanders, Andrew J., Mason, Malcolm David and Jiang, Wen Guo 2016. Importance of osteoprotegrin and receptor activator of nuclear factor kB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. International Journal of Oncology 48 (3) , pp. 919-928. 10.3892/ijo.2016.3339

Owen, Sioned, Sanders, Andrew J., Mason, Malcolm David and Jiang, Wen Guo 2016. Targeting of Receptor Activator of Nuclear Kappa B (RANK) in PC-3 cells increases cell proliferation and matrix adhesion in vitro. Anticancer Research 36 (3) , pp. 1127-1134.

Webber, Jason P., Spary, Lisa Kate, Mason, Malcolm David, Tabi, Zsuzsanna, Brewis, Ian Andrew and Clayton, Aled 2016. Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes. Oncotarget 7 , pp. 20124-20139. 10.18632/oncotarget.7716

Vale, Claire L., Burdett, Sarah, Rydzewska, Larysa H. M., Albiges, Laurence, Clarke, Noel W., Fisher, David, Fizazi, Karim, Gravis, Gwenaelle, James, Nicholas D., Mason, Malcolm David, Parmar, Mahesh K. B., Sweeney, Christopher J., Sydes, Matthew R., Tombal, Bertrand and Tierney, Jayne F. 2016. Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data. Lancet Oncology 17 (2) , pp. 243-256. 10.1016/S1470-2045(15)00489-1

Hamdy, Freddie, Donovan, Jenny, Lane, J. Athene, Mason, Malcolm, Metcalfe, Chris, Holding, Peter, Davis, Michael, Peters, Tim J., Turner, Emma L., Martin, Richard M., Oxley, Jon, Robinson, Mary, Staffurth, John, Walsh, Eleanor, Bollina, Prasad, Catto, James, Doble, Andrew, Doherty, Alan, Gillatt, David, Kockelbergh, Roger, Kynaston, Howard, Paul, Alan, Powell, Philip, Prescott, Stephen, Rosario, Derek J., Rowe, Edward and Neal, David E. 2016. 10-Year Outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. New England Journal of Medicine 375 (15) , pp. 1415-1424. 10.1056/NEJMoa1606220

Vale, C., Burdett, S., Rydzewska, L., Albiges, L., Clarke, N., Fisher, D., Fizazi, K., Gravis, G., James, N. D., Mason, Malcolm David, Parmar, M., Sweeney, C. J., Sydes, M., Tombal, B. and Tierney, J. 2015. Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data. The Lancet Oncology 17 (2) , pp. 243-256. 10.1016/ S1470-2045(15)00489-1

Collins, Ross J., Jiang, Wen Guo, Hargest, Rachel, Mason, Malcolm David and Sanders, Andrew James 2015. EPLIN: a fundamental actin regulator in cancer metastasis? Cancer and Metastasis Reviews 34 (4) , pp. 753-764. 10.1007/s10555-015-9595-8

Jiang, Wen Guo, Ye, Lin, Sanders, Andrew J., Sun, Ping-Hui, Ruge, Fiona, Lane, Jane, Satherley, Lucy, Weeks, Hoi, Gao, Y., Wei, C., Wu, Y. and Mason, Malcolm David 2015. 3117 Effects of YangZheng XiaoJi on the migration and growth of lung cancer cells, by targeting the Hepatocyte Growth Factor Receptor-Epidermal Growth Factor Receptor (HGFR-EGFR) transactivation. European Journal of Cancer 51 (Supp 1) , S642. 10.1016/S0959-8049(16)31758-0

Owen, S., Martin, Tracey Amanda, Dart, Dafydd Alwyn, Ablin, R. J., Mason, Malcolm David and Jiang, Wen Guo 2015. The prostate Transglutaminase, TGase-4, is potentially linked to the junctional proteins at tight junctions of prostate tissues and prostate cancer cells [Abstract]. European Journal of Cancer 51 (S3) , S481-S481. 10.1016/S0959-8049(15)30048-4

Jiang, Wen Guo, Ye, Lin, Sanders, Andrew James, Sun, Ping-Hui, Ruge, Fiona, Lane, Jane, Satherley, Lucy, Weeks, Hoi, Gao, Y., Wei, C., Wu, Y. and Mason, Malcolm David 2015. Effects of YangZheng XiaoJi on the migration and growth of lung cancer cells, by targeting the Hepatocyte Growth Factor Receptor-Epidermal Growth Factor Receptor (HGFR-EGFR) transactivation [Abstract]. European Journal of Cancer 51 (S3) , S642-S642. 10.1016/S0959-8049(15)30060-5

Owen, S., Dart, Dafydd Alwyn, Cui, Yuxin, Ablin, R., Mason, Malcolm David and Jiang, Wen Guo 2015. Potential interactions between Interleukin-20 and Transglutaminase 4 might affect prostate cancer cell function [Abstract]. European Journal of Cancer 51 (S3) , S26-S27. 10.1016/S0959-8049(16)30088-0

Ye, Lin, Jia, Yongning, Ji, Ke, Sanders, Andrew James, Xue, Kan, Ji, Jiafu, Mason, Malcolm David and Jiang, Wen Guo 2015. Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis (review). Oncology Letters 10 (3) , pp. 1240-1250. 10.3892/ol.2015.3459

Jiang, Wen Guo, Ye, Lin, Ruge, Fiona, Owen, Sioned, Martin, Tracey Amanda, Sun, Ping-Hui, Sanders, Andrew James, Lane, Jane, Satherley, Lucy, Weeks, Hoi P., Gao, Yong, Wei, Cong, Wu, Yiling and Mason, Malcolm David 2015. YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells. Journal of Translational Medicine 13 , 280. 10.1186/s12967-015-0639-1

Valdagni, Riccardo, Van Poppel, Hendrik, Aitchison, Michael, Albers, Peter, Berthold, Dominik, Bossi, Alberto, Brausi, Maurizio, Denis, Louis, Drudge-Coates, Lawrence, De Santis, Maria, Feick, Günther, Harrison, Chris, Haustermans, Karin, Hollywood, Donal, Hoyer, Morton, Hummel, Henk, Mason, Malcolm David, Mirone, Vincenzo, Müller, Stefan C., Parker, Chris, Saghatchian, Mahasti, Sternberg, Cora N., Tombal, Bertrand, van Muilekom, Erik, Watson, Maggie, Wesselmann, Simone, Wiegel, Thomas, Magnani, Tiziana and Costa, Alberto 2015. Prostate Cancer Unit Initiative in Europe: a position paper by the European School of Oncology. Critical Reviews in Oncology/Hematology 95 (2) , pp. 133-143. 10.1016/j.critrevonc.2015.05.014

Mason, Malcolm David and Lester, Jason 2015. Cardiovascular effects of hormone therapy for prostate cancer. Drug, Healthcare and Patient Safety 7 , pp. 129-138. 10.2147/DHPS.S50549

Mason, Malcolm David, Parulekar, W. R., Sydes, M. R., Brundage, M., Kirkbride, P., Gospodarowicz, M., Cowan, R., Kostashuk, E. C., Anderson, J., Swanson, G., Parmar, M. K. B., Hayter, C., Jovic, G., Hiltz, A., Hetherington, J., Sathya, J., Barber, J. B. P., McKenzie, M., El-Sharkawi, S., Souhami, L., Hardman, P. D. J., Chen, B. E. and Warde, P. 2015. Final report of the intergroup randomized study of combined androgen-deprivation therapy plus radiotherapy versus androgen-deprivation therapy alone in locally advanced prostate cancer. Journal of Clinical Oncology 33 (19) , pp. 2143-2150. 10.1200/JCO.2014.57.7510

Brundage, M., Sydes, M. R., Parulekar, W. R., Warde, P., Cowan, R., Bezjak, A., Kirkbride, P., Parliament, M., Moynihan, C., Bahary, J.-P., Parmar, M. K. B., Sanders, K., Chen, B. E. and Mason, Malcolm David 2015. Impact of radiotherapy when added to androgen-deprivation therapy for locally advanced prostate cancer: long-term quality-of-life outcomes from the NCIC CTG PR3/MRC PR07 randomized trial. Journal of Clinical Oncology 33 (19) , pp. 2151-2157. 10.1200/JCO.2014.57.8724

James, Nicholas David, Spears, Melissa R., Clarke, Noel W., Dearnaley, David P., De Bono, Johann S., Gale, Joanna, Hetherington, John, Hoskin, Peter J., Jones, Robert J., Laing, Robert, Lester, Jason F., McLaren, Duncan, Parker, Christopher C., Parmar, Mahesh K.B., Ritchie, Alastair W.S., Russell, J. Martin, Strebel, Räto T., Thalmann, George N., Mason, Malcolm David and Sydes, Matthew R. 2015. Survival with newly diagnosed metastatic prostate cancer in the 'Docetaxel Era': data from 917 patients in the control arm of the STAMPEDE trial (MRC PR08, CRUK/06/019). European Urology 67 (6) , pp. 1028-1038. 10.1016/j.eururo.2014.09.032

Salimu, Josephine, Spary, Lisa Kate, Al-Taei, Saly, Clayton, Aled, Mason, Malcolm David, Staffurth, John and Tabi, Zsuzsanna 2015. Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells--A Key Role for Heat-Shock Protein 70 and Receptor CD91. Cancer Immunology Research 3 (6) , pp. 678-688. 10.1158/2326-6066.CIR-14-0079

Jiang, Wen, Ye, Lin, Ruge, Fiona, Sun, Ping-Hui, Sanders, Andrew James, Ji, Ke, Lane, Jane, Zhang, Lei, Satherley, Lucy, Weeks, Hoi, Zhi, X., Gao, Y., Wei, C., Wu, Y. and Mason, Malcolm David 2015. Expression of Sonic Hedgehog (SHH) in human lung cancer and the impact of YangZheng XiaoJi on SHH-mediated biological function of lung cancer cells and tumor growth. Anticancer Research 35 (3) , pp. 1321-1331.

Chowdhury, Ridwana, Webber, Jason P., Gurney, Mark, Mason, Malcolm David, Tabi, Zsuzsanna and Clayton, Aled 2015. Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts. Oncotarget 5

Webber, Jason P., Spary, Lisa Kate, Sanders, Andrew James, Chowdhury, Ruhena, Jiang, Wen, Steadman, Robert, Wymant, Jennifer, Jones, Arwyn Tomos, Kynaston, Howard, Mason, Malcolm David, Tabi, Zsuzsanna and Clayton, Aled 2015. Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes. Oncogene 34 , pp. 290-302. 10.1038/onc.2013.560

Spary, Lisa Kate, Salimu, Josephine, Webber, Jason P., Clayton, Aled, Mason, Malcolm david and Tabi, Zsuzsanna 2014. Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14+PD-L1+phenotype in prostate cancer. OncoImmunology 3 (9) , e955331. 10.4161/21624011.2014.955331

Attard, Gerhardt, Sydes, Matthew R., Mason, Malcolm, Clarke, Noel W., Aebersold, Daniel, de Bono, Johann S., Dearnaley, David P., Parker, Chris C., Ritchie, Alastair W.S., Russell, J. Martin, Thalmann, George, Cassoly, Estelle, Millman, Robin, Matheson, David, Schiavone, Francesca, Spears, Melissa R., Parmar, Mahesh K.B. and James, Nicholas D. 2014. Combining enzalutamide with abiraterone, prednisone, and androgen deprivation therapy in the STAMPEDE trial. European Urology 66 (5) , pp. 799-802. 10.1016/j.eururo.2014.05.038

Ye, Lin, Sun, Ping-Hui, Sanders, Andrew James, Martin, Tracey Amanda, Lane, Jane, Mason, Malcolm David and Jiang, Wen Guo 2014. Therapeutic potential of capillary morphogenesis gene 2 extracellular vWA domain in tumour-related angiogenesis. International Journal of Oncology 45 (4) , pp. 1565-1573. 10.3892/ijo.2014.2533

Ji, Ke, Ye, Lin, Ruge, Fiona, Hargest, Rachel, Mason, Malcolm David and Jiang, Wen Guo 2014. Implication of metastasis suppressor gene, Kiss-1 and its receptor Kiss-1R in colorectal cancer. BMC Cancer 14 , 723. 10.1186/1471-2407-14-723

Lane, J. Athene, Donovan, Jenny L ., Davis, Michael, Walsh, Eleanor, Dedman, Daniel, Down, Liz, Turner, Emma L., Mason, Malcolm David, Metcalfe, Chris, Peters, Tim J., Martin, Richard M., Neal, David E. and Hamdy, Freddie C. 2014. Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. Lancet Oncology 15 (10) , pp. 1109-1118. 10.1016/S1470-2045(14)70361-4

Sanders, Andrew James, Ye, Lin, Li, Jin, Mason, Malcolm David and Jiang, Wen Guo 2014. Tumour angiogenesis and repulsive guidance molecule b: A role in HGF- and BMP-7-mediated angiogenesis. International Journal of Oncology 45 (3) , pp. 1304-1312. 10.3892/ijo.2014.2508

Webber, Colleen, Gospodarowicz, Mary, Sobin, Leslie H., Wittekind, Christian, Greene, Frederick L., Mason, Malcolm David, Compton, Carolyn, Brierley, James and Groome, Patti A 2014. Improving the TNM classification: findings from a 10-year continuous literature review. International Journal of Cancer 135 (2) , pp. 371-378. 10.1002/ijc.28683

Martin, Tracey Amanda, Mason, Malcolm David and Jiang, Wen Guo 2014. HGF and the regulation of tight junctions in human prostate cancer cells. Oncology Reports 32 (1) , pp. 213-224. 10.3892/or.2014.3219

Ye, Lin, Sanders, Andrew James, Sun, Ping-Hui, Mason, Malcolm David and Jiang, Wen Guo 2014. Capillary morphogenesis gene 2 regulates adhesion and invasiveness of prostate cancer cells. Onology Letters 7 (6) , pp. 2149-2153. 10.3892/ol.2014.2038

Ye, Lin, Sun, Ping-Hui, Malik, Muhammad Faraz Arshad, Mason, Malcolm David and Jiang, Wen Guo 2014. Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis. Journal of Cancer Research and Clinical Oncology 140 (6) , pp. 957-967. 10.1007/s00432-014-1650-2

Webber, Jason P., Stone, Timothy C., Katilius, Evaldas, Smith, Breanna, Gordon, Bridget, Mason, Malcolm David, Tabi, Zsuzsanna, Brewis, Ian Andrew and Clayton, Aled 2014. Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscanTM) platform. Molecular & Cellular Proteomics 13 (4) , pp. 1050-1064. 10.1074/mcp.M113.032136

Spary, Lisa Kate, Al-Taei, Saly, Salimu, Josephine, Cook, Alexander, Ager, Ann, Watson, Heulwen Angharad, Clayton, Aled, Staffurth, John Nicholas, Mason, Malcolm David and Tabi, Zsuzsanna 2014. Enhancement of T cell responses as a result of synergy between lower doses of radiation and T cell stimulation. The Journal of Immunology 192 (7) , pp. 3101-3110. 10.4049/jimmunol.1302736

Heidenreich, Axel, Bracarda, Sergio, Mason, Malcolm David, Ozen, Haluk, Sengelov, Lisa, Van Oort, Inge, Papandreou, Christos, Fossa, Sophie, Hitier, Simon and Climent, Miguel Angel 2014. Safety of cabazitaxel in senior adults with metastatic castration-resistant prostate cancer: results of the European compassionate-use programme. European Journal of Cancer 50 (6) , pp. 1090-1099. 10.1016/j.ejca.2014.01.006

Slusarczyk, Magdalena, Huerta Lopez, Monica, Balzarini, Jan, Mason, Malcolm David, Jiang, Wen Guo, Blagden, Sarah, Thompson, Emely, Ghazaly, Essam and McGuigan, Christopher 2014. Application of ProTide technology to Gemcitabine: A successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development. Journal of Medicinal Chemistry 57 (4) , pp. 1531-1542. 10.1021/jm401853a

Galazi, Myria, Rodriguez-Vida, Alejo, Ng, Tony, Mason, Malcolm David and Chowdhury, Simon 2014. Precision medicine for prostate cancer. Expert Review of Anticancer Therapy 14 (11) , pp. 1305-1315. 10.1586/14737140.2014.972948

Ye, Lin, Sun, Ping-Hui, Martin, Tracey Amanda, Sanders, Andrew James, Mason, Malcolm David and Jiang, Wen Guo 2013. Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells. Urologic Oncology: Seminars and Original Investigations 31 (8) , pp. 1576-1583. 10.1016/j.urolonc.2012.05.006

Sun, Ping-Hui, Ye, Lin, Mason, Malcolm David and Jiang, Wen Guo 2013. Receptor-like protein tyrosine phosphatase κ negatively regulates the apoptosis of prostate cancer cells via the JNK pathway. International Journal of Oncology 43 (5) , pp. 1560-1568. 10.3892/ijo.2013.2082

Jiang, Wen Guo, Ye, Lin, Sanders, Andrew James, Ruge, Fiona, Kynaston, Howard, Ablin, Richard J. and Mason, Malcolm David 2013. Prostate transglutaminase (TGase-4, TGaseP) enhances the adhesion of prostate cancer cells to extracellular matrix, the potential role of TGase-core domain. Journal of Translational Medicine 11 , 269. 10.1186/1479-5876-11-269

Ji, Ke, Ye, Lin, Mason, Malcolm David and Jiang, Wen Guo 2013. The Kiss‑1/Kiss‑1R complex as a negative regulator of cell motility and cancer metastasis (Review). International Journal of Molecular Medicine 32 (4) , pp. 747-754. 10.3892/ijmm.2013.1472

Ye, Lin, Mason, Malcolm David and Jiang, Wen Guo 2013. Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis [Abstract]. European Journal of Cancer 49 , S151-S151. 10.1016/S0959-8049(13)70060-1

Owen, S., Sanders, Andrew James, Ye, Lin, Mason, Malcolm David and Jiang, Wen Guo 2013. Osteomodulin expression profile in human breast cancer [Abstract]. European Journal of Cancer 49 , S197-S197. 10.1016/S0959-8049(13)70061-3

Martin, Tracey Amanda, Mason, Malcolm David and Jiang, Wen Guo 2013. HGF and the regulation of tight junctions in human prostate cancer cells. European Journal of Cancer 49 , S132-S132.

Sobkowicz, A., Sanders, Andrew James, Mason, Malcolm David and Jiang, Wen Guo 2013. Paxillin in the prostate cancer cell models [Abstract]. European Journal of Cancer 49 , S686-S687.

Sanders, Andrew James, Sobkowicz, A., Owen, S., Ye, Lin, Mason, Malcolm David and Jiang, Wen Guo 2013. A role for activated leukocyte cell adhesion molecule (ALCAM) in the growth and matrix adhesion of prostate cancer cells [Abstract]. European Journal of Cancer 49 , S685-S685.

Ye, Lin, Mason, Malcolm David and Jiang, Wen Guo 2013. Capillary morphogenesis gene 2 is a potential target for anti-angiogenic therapy [Abstract]. European Journal of Cancer 49 , S163-S164.

Jiang, Wen, Ye, Lin, Ji, K., Ruge, F., Sun, P.H., Ji, J.F., Gao, Y., Wu, Y.L. and Mason, Malcolm 2013. Inhibitory effect of Yangzheng Xiaoji on the ARK/Aurora pathways and in vivo tumour growth of human osteosarcoma. European Journal of Cancer 49 (Supp 2) , S892.

Jiang, Wen Guo, Ye, Lin, Ji, Ke, Ruge, Fiona, Wu, Yiling, Gao, Yong, Ji, Jiafu and Mason, Malcolm David 2013. Antitumour effects of Yangzheng Xiaoji in human osteosarcoma: The pivotal role of focal adhesion kinase signalling. Oncology Reports 30 (3) , pp. 1405-1413. 10.3892/or.2013.2586

Courtier, Nicholas, Gambling, Tina, Enright, Stephanie, Barrett-Lee, Peter, Abraham, J. and Mason, Malcolm David 2013. A prognostic tool to predict fatigue in women with early-stage breast cancer undergoing radiotherapy. The Breast 22 (4) , pp. 504-509. 10.1016/j.breast.2012.10.002

Sun, Ping-Hui, Ye, Lin, Mason, Malcolm David and Jiang, Wen Guo 2013. Transmembrane phosphatases and cancer development, the role of Protein Tyrosine Phosphatase-kappa (PTP) and Protein Tyrosine Phosphatase-mu (PTP mu). Current Signal Transduction Therapy 8 (2) , pp. 129-141.

Sun, Ping-Hui, Ye, Lin, Mason, Malcolm David and Jiang, Wen Guo 2013. Protein tyrosine phosphatase kappa (PTPRK) is a negative regulator of adhesion and invasion of breast cancer cells, and associates with poor prognosis of breast cancer. Journal of Cancer Research and Clinical Oncology 139 (7) , pp. 1129-1139. 10.1007/s00432-013-1421-5

Parker, C. C., Sydes, M. R., Mason, Malcolm, Clarke, N. W., Aebersold, D., de Bono, J. S., Dearnaley, D. P., Ritchie, A. W.S., Russell, J. M., Thalmann, G., Parmar, M. K. B. and James, N. D. 2013. Prostate radiotherapy for men with metastatic disease: A new comparison in the STAMPEDE trial [editorial]. Clinical Oncology 25 (5) , pp. 318-320. 10.1016/j.clon.2013.01.005

Parker, C., Sydes, M., Mason, Malcolm David, Clarke, N., Aebersold, D., de Bono, J., Dearnaley, D., Ritchie, A., Russell, J., Thalmann, G., Parmar, M. and James, N. 2013. Prostate radiotherapy for men with metastatic disease: a new comparison in the Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy (STAMPEDE) trial. BJU International 111 (5) , pp. 697-699. 10.1111/bju.12087

Webb, Siobhan L., Sanders, Andrew James, Mason, Malcolm David and Jiang, Wen Guo 2013. Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivo. Molecular and Cellular Biochemistry 375 (1-2) , pp. 207-217. 10.1007/s11010-012-1544-z

Courtier, Nicholas, Gambling, Tina, Enright, Stephanie, Barrett-Lee, Peter, Abraham, Jacinta and Mason, Malcolm David 2013. Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancer. Supportive Care in Cancer 21 (1) , pp. 173-181. 10.1007/s00520-012-1508-6

Owen, Sioned, Ye, Lin, Sanders, Andrew, Mason, Malcolm and Jiang, Wen 2013. Expression profile of receptor activator of nuclear-kappa B (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. Anticancer Research 33 (1) , pp. 199-206.

Sun, Ping-Hui, Ye, Lin, Mason, Malcolm and Jiang, Wen 2012. Protein tyrosine phosphatase µ (PTP µ or PTPRM), a negative regulator of proliferation and invasion of breast cancer cells, is associated with disease prognosis. Plos One 7 (11) , e50183. 10.1371/journal.pone.0050183

Jiang, Wen Guo, Ye, Lin, Ji, Ke, Frewer, Natasha, Ji, Jiafu and Mason, Malcolm David 2012. Inhibitory effects of Yangzheng Xiaoji on angiogenesis and the role of the focal adhesion kinase pathway. International Journal of Oncology 41 (5) , pp. 1635-1642. 10.3892/ijo.2012.1627

Webb, Siobhan L., Sanders, Andrew James, Mason, Malcolm and Jiang, Wen 2012. The influence of matriptase-2 on prostate cancer in vitro: a possible role for β-catenin. Oncology Reports 28 (4) , pp. 1491-1497. 10.3892/or.2012.1945

Sydes, Matthew R., Parmar, Mahesh K. B., Mason, Malcolm David, Clarke, Noel W., Amos, Claire, Anderson, John, de Bono, Johann, Dearnaley, David P., Dwyer, John, Green, Charlene, Jovic, Gordana, Ritchie, Alastair W. S., Russell, J., Sanders, Karen, Thalmann, George and James, Nicholas D. 2012. Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial. Trials 13 (1) , pp. 168-181. 10.1186/1745-6215-13-168

Meeks, Joshua J., Bellmunt, Joaquim, Bochner, Bernard H., Clarke, Noel W., Daneshmand, Siamak, Galsky, Matthew D., Hahn, Noah M., Lerner, Seth P., Mason, Malcolm David, Powles, Thomas, Sternberg, Cora N. and Sonpavde, Guru 2012. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. European Urology 62 (3) , pp. 523-533. 10.1016/j.eururo.2012.05.048

Payne, Heather, Bahl, Amit, Mason, Malcolm David, Troup, Janis and De Bono, Johann 2012. Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities. British Journal of Urology International 110 (5) , pp. 658-667. 10.1111/j.1464-410X.2011.10886.x

Al-Taei, Saly, Salimu, Josephine, Lester, Jason F., Linnane, Seamus, Goonewardena, Madusha, Harrop, Richard, Mason, Malcolm David and Tabi, Zsuzsanna 2012. Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma. Lung Cancer 77 (2) , pp. 312-318. 10.1016/j.lungcan.2012.03.008 Item availability restricted.

Shore, N., Mason, Malcolm David and de Reijke, Th. M. 2012. New developments in castrate-resistant prostate cancer. British Journal of Urology International 109 (s6) , pp. 22-32. 10.1111/j.1464-410X.2012.11217.x

Wolff, J. M. and Mason, Malcolm David 2012. Drivers for change in the management of prostate cancer - guidelines and new treatment techniques. British Journal of Urology International 109 (s6) , pp. 33-41. 10.1111/j.1464-410X.2012.11218.x

Dunlop, Malcolm G., Dobbins, Sara E., Farrington, Susan Mary, Jones, Angela M., Palles, Claire, Whiffin, Nicola, Tenesa, Albert, Spain, Sarah, Broderick, Peter, Ooi, Li-Yin, Domingo, Enric, Smillie, Claire, Henrion, Marc, Frampton, Matthew, Martin, Lynn, Grimes, Graeme, Gorman, Maggie, Semple, Colin, Ma, Yusanne P., Barclay, Ella, Prendergast, James, Cazier, Jean-Baptiste, Olver, Bianca, Penegar, Steven, Lubbe, Steven, Chander, Ian, Carvajal-Carmona, Luis G., Ballereau, Stephane, Lloyd, Amy, Vijayakrishnan, Jayaram, Zgaga, Lina, Rudan, Igor, Theodoratou, Evropi, Thomas, Huw, Maher, Eamonn, Evans, Gareth, Walker, Lisa, Halliday, Dorothy, Lucassen, Anneke, Paterson, Joan, Hodgson, Shirley, Homfray, Tessa, Side, Lucy, Izatt, Louise, Donaldson, Alan, Tomkins, Susan, Morrison, Patrick, Brewer, Carole, Henderson, Alex, Davidson, Rosemarie, Murday, Victoria, Cook, Jaqueline, Haites, Neva, Bishop, Timothy, Sheridan, Eamonn, Green, Andrew, Marks, Christopher, Carpenter, Sue, Broughton, Mary, Greenhalge, Lynn, Suri, Mohnish, Starr, John M., Deary, Ian, Kirac, Iva, Kovacevi, Dujo, Aaltonen, Lauri A., Renkonen-Sinisalo, Laura, Mecklin, Jukka-Pekka, Matsuda, Koichi, Nakamura, Yusuke, Okada, Yukinori, Gallinger, Steven, Duggan, David J., Conti, David, Newcomb, Polly, Hopper, John, Jenkins, Mark A., Schumacher, Fredrick, Casey, Graham, Easton, Douglas, Shah, Mitul, Pharoah, Paul, Lindblom, Annika, Liu, Tao, Edler, David, Lenander, Claes, Dalén, Johan, Hjern, Fredrik, Lundqvist, Nils, Lindforss, Ulrik, Påhlman, Lars, Smedh, Kennet, Törnqvist, Anders, Holm, Jörn, Janson, Martin, Andersson, Magnus, Ekelund, Susanne, Olsson, Louise, Smith, Chris, West, Hannah, Cheadle, Jeremy Peter, MacDonald, Graham, Samuel, Leslie M., Ahmad, Athar, Corrie, Philippa, Jodrell, Duncan, Palmer, Cheryl, Wilson, Charles, O'Hagan, Julie, Smith, David, McDermott, Ray, Walshe, Janice, Cassidy, James, McDonald, Alec, Mohammed, Nazia, White, Jeff, Yosef, Hosney, Breathnach, Oscar, Grogan, Liam, Thomas, Robert, Eatock, Martin, Henry, Paul, Houston, Russell, Johnston, Patrick, Wilson, Richard, Geh, Ian, Danwata, Falalu, Hindley, Andrew, Susnerwala, Shabbir, Bradley, Chris, Conn, Andrew, Raine, Anne, Twelves, Chris, Falk, Stephen, Hopkins, Kirstin, Tahir, Saad, Dhadda, Amandeep, Maraveyas, Anthony, Sgouros, Joseph, Teo, Mark, Ahmad, Rizvana, Cleator, Susan, Creak, Antonia, Lowdell, Charles, Riddle, Philippa, Benstead, Kim, Farrugia, David, Reed, Nicholas, Shepherd, Stephen, Levine, Edward, Mullamitha, Saifee, Saunders, Mark, Valle, Juan, Wilson, Gregory, Jones, Adam, Weaver, Andrew, Clark, Peter I., Haylock, Brain, Iqbal, Mussawar I., Myint, Arthur S., Smith, David, Beesley, Sharon, Sevitt, Timothy, Nicoll, Jonathan, Daniel, Francis, Ford, Victoria, Talbot, Toby, Butt, Mohammad, Hamid, Abdel, Mack, Paul, Roy, Raj, Osborne, Richard, McKinna, Fiona, Alsab, Heidar, Basu, Devyanee, Murray, Phillip, Sizer, Bruce, Azam, Faisal A., Neupane, Rekha, Waterston, Ashita, Glaholm, John, Blesing, Claire, Lowndes, Sarah, Medisetti, Aruna, Gaya, Andrew, Leslie, Martin, Maisey, Nicholas, Ross, Paul, Dunn, Grainne, Al-Salihi, Omar, Wasan, Harpreet S., Palmer, Cheryl, Tan, Li Tee, Dent, Jo, Hofmann, Uschi, Joffe, Johnathan K., Sherwin, Elizabeth, Soomal, Rabinder, Chakrabarti, Amitabha, Joseph, Shibu, Van der Voet, Johannes, Wadd, Nicholas J., Wilson, David, Anjarwalia, Salim, Hall, Julia, Hughes, Rob, Polychronis, Andrew, Scarffe, John H., Hill, Mark, James, Rodger D., Shah, Riyaz, Summers, Jeffrey, Hartley, Andrew, Carney, Desmond, McCaffrey, John, Bystricky, Brano, O'Reilly, Seamus, Gupta, Rajnish, Al-Mishlab, Talib, Gidden, Fiona, O'Hara, Richard, Stewart, Jill, Ashford, Richard, Glynne-Jones, Robert, Harrison, Mark, Mawdsley, Suzannah, Barlow, Hilary, Tighe, Mary, Walther, Julie, Neal, Janet, Rees, Charlotte, Bridgewater, John, Karp, Stephen, McGovern, Ursula, Atherton, Philip J., El-deeb, Hany, Macmillan, Craig, Patel, Kinnari, Bessell, Eric Michael, Dickinson, Peter D., Potter, Vanessa, Jephcott, Catherine, McAdam, Karen, Wrigley, Jessica, Osborne, Richard, Muthuramalingam, Sethupathi, O'Callaghan, Anne, Bridgewater, John, Melcher, Lucinda, Braconi, Chiara, Geh, Ju Ian, Palmer, Dan, Narayana, Priya, Steven, Neil, Gaya, Andres, Maisey, Nicholas, Rudman, Sarah, Chakraborti, Prabir, Kelly, Kay, Macgregor, Carol, Whillis, David, Freebairn, Alice, Gildersleve, James, Sharif, Sahid, Astras, George, Hickish, Tamas, Beech, Darren, Ellis, Richard, Kulkarni, Rajendra, Shankland, K., Begent, Richard, Mayer, Astrid, Meyer, Timothy, Strauss, Sandra, Hall, Viriginia, Raj, Sanjay, Chau, Ian, Cunningham, David, Birtle, Alison, Biswas, Ashoke, Susnerwala, Shabbir, Wise, Marcus, Cummins, Sebastian, Essapen, Sharadah, Middleton, Gary, Topham, Claire, Langley, Ruth, McKinna, Fiona, Webb, Andrew, Wilkins, Marie, Iveson, Timothy John, Dhadda, Amandeep, Hamid, Abdel, Askill, Colin, Wagstaff, John, Azzabi, Ashraf, Bateman, Adrian, Prejbisz, Jan, Tsang, David, Ali, Nasim, Jones, Amanda, O'Neill, Paul, Cottrill, Christopher, Propper, David, Lofts, Fiona Jane, Kennedy, James, Anthoney, David A., Cooper, Rachel, Crellin, Adrian, Melcher, Alan, Seymour, Matthew, Baughan, Christopher, Alexander, Emma, Cleator, Susan, Crown, John, Fennelly, David, Adab, Fawzi, Giridharan, Selvaraj, Pedley, Ian, Wright, Kathryn, Bliss, Peter, Cogill, Geoffrey, Lo, Nangi, Toy, Elizabeth, Bridgewater, John, Hochhauser, Daniel, Ledermann, Jonathan, Brewster, A. E., Maughan, Timothy Stanley, Mort, Diana, Mukherjee, Somnath, Dobrowsky, Werner, Calvert, Paula, Leonard, Gregory, Ahmad, Rizvana, Ford, Hugo, Moody, Anne Margeret, Goriah, Sonia, Wilkins, Margeret, Clive, Sally, Dawson, Lesley, McLean, Catriona, Phillips, Hamish Andrew, Gopi, Kakumudi, Tomlinson, Marjorie, Clenton, Susan, Furniss, Debra, Hornbuckle, Joanne, Pledge, Simon, Wadsley, Jonathan, Abbas, Mohammed, Marshall, Ernest, Harper-Wynne, Catherine, Barnes, Anne, Kumar, Satish, Vigneswaran, Vallipuram, Farrugia, David, Webb, Andrew, Gollins, Simon, Falk, Stephen, Genton, M., Sparrow, Geoff, Bale, Catherine, Fuller, C., Mullard, Anna, Stuart, Nicholas, Williams, Rachel, Keane, Maccon, Maughan, Tim, Seymour, Matthew, Wilson, Richard, Wasan, Harpreet, Adams, Richard Alexander, Madi, Ayman, Cassidy, James, Kennedy, James, Hodgkinson, Elizabeth, Rogers, Penny, Pope, Malcolm, Kaplan, Rick, Meade, Angela, Parmar, Mahesh, Kenny, Sarah, Fisher, David, Harper, Lynda, Mitchell, Jena, Nichols, Laura, Sydes, Benjamin, Clement, Louise, Kay, Edward, Courtney, Cheryl, Gallagher, Madalena, Murphy, Claire, Thompson, Lindsay, Beall, Sarah, Hassan, Sharma, Gracie, Richard, Griffiths, Gareth O., Mason, Malcolm David, Parker, Chris, Rudd, Robin, Johnson, Patrick, Whelan, Jeremy, Northover, John, Brown, Julia, Aapro, Matti, Stout, Ronald, Midgley, Rachel, Kerr, David J., Campbell, Harry, Tomlinson, Ian P. and Houlston, Richard S. 2012. Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk [Letter]. Nature Genetics 44 (7) , pp. 770-776. 10.1038/ng.2293

James, Nicholas D., Sydes, Matthew R., Mason, Malcolm David, Clarke, Noel W., Anderson, John, Dearnaley, David P., Dwyer, John, Jovic, Gordana, Ritchie, Alastair W. S., Russell, J. Martin, Sanders, Karen, Thalmann, George N., Bertelli, Gianfilippo, Birtle, Alison J., O'Sullivan, Joe M., Protheroe, Andrew, Sheehan, Denise, Srihari, Narayanan and Parmar, Mahesh K. B. 2012. Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: First results from the STAMPEDE multiarm, multistage, randomised controlled trial. The Lancet Oncology 13 (5) , pp. 549-558. 10.1016/S1470-2045(12)70088-8

Mason, Malcolm David, Parulekar, Wendy, Sydes, Matthew Robert, Parmar, Mahesh, Anderson, John, Barber, Jim, Brundage, Michael Donald, Cowan, Richard, Gospodarowicz, Mary K., Hayter, Charles, Hetherington, John, Hiltz, Andrea Clare, Kirkbride, Peter, Kostashuk, Edward, Sanders, Karen, Sathya, Jinka, Swanson, Gregory P., Chen, Bingshu E. and Warde, Padraig Richard 2012. Final analysis of intergroup randomized phase III study of androgen deprivation therapy (ADT) plus radiation therapy (RT) in locally advanced prostate cancer (CaP) (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110) [Abstract]. Journal of Clinical Oncology 30 (15S) , 4509.

Nunes, Claudia Trindade, Wong, Ryan Francis, Mason, Malcolm David, Fegan, Christopher Daniel, Man, Stephen Tzekwung and Pepper, Christopher John 2012. Expansion of a CD8+PD-1+ replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression. Clinical Cancer Research 18 (3) , pp. 678-687. 10.1158/1078-0432.CCR-11-2630

Shelley, Mike D., Jones, Gabriel, Cleves, Anne, Wilt, Timothy J., Mason, Malcolm David and Kynaston, Howard 2012. Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review. British Journal of Urology International 109 (4) , pp. 496-505. 10.1111/j.1464-410X.2011.10880.x

Bahl, A. K., Masson, S., Malik, Z., Birtle, A., Sundar, S., Jones, R., James, N., Mason, Malcolm David, Kumar, S., Bottomley, D., Lydon, A., Chowdhury, S., Wylie, J. and De Bono, J. 2012. Cabazitaxel for metastatic castration resistant prostate cancer (mCRPC): Interim safety and quality of life (QOL) data from the UK early access programme [Abstract]. European Urology Supplements 11 (1) , e129. 10.1016/S1569-9056(12)60128-6

Jones, Gabriel, Cleves, Anne, Wilt, Timothy J., Mason, Malcolm David, Kynaston, Howard and Shelley, Mike 2012. Intravesical gemcitabine for non-muscle invasive bladder cancer. Cochrane Database of Systematic Reviews 1 , CD009294. 10.1002/14651858.CD009294.pub2

Nur, Ula, Rachet, Bernard, Parmar, Mahesh K. B., Sydes, Mathew R., Cooper, Nicola, Stenning, Sally, Read, Graham, Oliver, Tim, Mason, Malcolm David and Coleman, Michel P. 2012. Socio-economic inequalities in testicular cancer survival within two clinical studies. Cancer Epidemiology 36 (2) , pp. 217-221. 10.1016/j.canep.2011.07.008

Gnanapragasam, Vincent J., Mason, Malcolm David, Shaw, Greg L. and Neal, David E. 2012. The role of surgery in high-risk localised prostate cancer. BJU International 109 (5) , pp. 648-658. 10.1111/j.1464-410X.2011.10596.x

Warde, Padraig, Mason, Malcolm David, Ding, Keyue, Kirkbride, Peter, Brundage, Michael, Cowan, Richard, Gospodarowicz, Mary, Sanders, Karen, Kostashuk, Edmund, Swanson, Greg, Barber, Jim, Hiltz, Andrea, Parmar, Mahesh K .B., Sathya, Jinka, Anderson, John, Hayter, Charles, Hetherington, John, Sydes, Matthew R. and Parulekar, Wendy 2011. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: A randomised, phase 3 trial. The Lancet 378 (9809) , pp. 2104-2111. 10.1016/S0140-6736(11)61095-7

Nunes, Claudia Trindade, Miners, Kelly Louise, Dolton, Garry Michael, Pepper, Christopher John, Fegan, Christopher Daniel, Mason, Malcolm David and Man, Stephen Tzekwung 2011. A novel tumor antigen derived from enhanced degradation of Bax protein in human cancers. Cancer Research 71 (16) , pp. 5435-5444. 10.1158/0008-5472.CAN-11-0393

Clayton, Aled, Al-Taei, Saly, Webber, Jason P., Mason, Malcolm David and Tabi, Zsuzsanna 2011. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. The Journal of Immunology 187 (2) , pp. 676-683. 10.4049/jimmunol.1003884

Sanders, Andrew James, Martin, Tracey Amanda, Ye, Lin, Mason, Malcolm David and Jiang, Wen Guo 2011. EPLIN is a negative regulator of prostate cancer growth and invasion. The Journal of Urology 186 (1) , pp. 295-301. 10.1016/j.juro.2011.03.038

Mottet, Nicolas, Bellmunt, Joaquim, Bolla, Michel, Joniau, Steven, Mason, Malcolm David, Matveev, Vsevolod, Schmid, Hans-Peter, Van der Kwast, Theo, Wiegel, Thomas, Zattoni, Filiberto and Heidenreich, Axel 2011. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer. European Urology 59 (4) , pp. 572-583. 10.1016/j.eururo.2011.01.025

Mottet, N., Bellmunt, J., Bolla, M., Joniau, S., Mason, Malcolm David, Matveev, V., Schmid, H. P., van der Kwast, T., Wiegel, T., Zattoni, F. and Heidenreich, A. 2011. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer - Guía de la EAU sobre el cáncer de próstata. Parte II: tratamiento del cáncer de próstata avanzado, recidivante y resistente a la castración. Actas Urológicas Españolas 35 (10) , pp. 565-579. 10.1016/j.acuroe.2012.01.001

Heidenreich, A., Bellmunt, J., Bolla, M., Joniau, S., Mason, Malcolm David, Matveev, V., Mottet, N., Schmid, H. P., van der Kwast, T., Wiegel, T. and Zattoni, F. 2011. EAU guidelines on prostate cancer. Part I: screening, diagnosis, and treatment of clinically localised disease - Guía de la EAU sobre el cáncer de próstata. Parte I: cribado, diagnóstico y tratamiento del cáncer clínicamente localizado. Actas Urológicas Españolas 35 (9) , pp. 501-514. 10.1016/j.acuroe.2011.12.003

Courtier, Nicholas, Gambling, Tina, Barrett-Lee, Peter, Abraham, Jincy and Mason, Malcolm David 2011. Hepatic Irradiation during Modern Radiotherapy Protocols after Breast Conservation [Abstract]. Clinical Oncology 23 (3) , pp. 199-203. 10.1016/j.clon.2011.01.363

Martin, Tracey Amanda, Harrison, Gregory M., Mason, Malcolm David and Jiang, Wen Guo 2011. HAVcR-1 reduces the integrity of human endothelial tight junctions. Anticancer Research 31 (2) , pp. 467-473.

Ye, Lin, Mason, Malcolm David and Jiang, Wen Guo 2011. Bone morphogenetic protein and bone metastasis, implication and therapeutic potential. Frontiers in Bioscience 16 , pp. 865-897.

Webb, Siobhan L., Sanders, Andrew James, Mason, Malcolm David and Jiang, Wen Guo 2011. Type II transmembrane serine protease (TTSP) deregulation in cancer. Frontiers in Bioscience 16 , pp. 539-552.

Heidenreich, Axel, Bellmunt, Joaquim, Bolla, Michel, Joniau, Steven, Mason, Malcolm David, Matveev, Vsevolod, Mottet, Nicolas, Schmid, Hans-Peter, van der Kwast, Theo, Wiegel, Thomas and Zattoni, Filliberto 2011. EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease. European Urology 59 (1) , pp. 61-71. 10.1016/j.eururo.2010.10.039

Martin, Tracey Amanda, Mason, Malcolm David and Jiang, Wen Guo 2011. Hepatocyte growth factor signalling in cancer metastasis. Current Signal Transduction Therapy 6 (2) , pp. 180-190. 10.2174/157436211795659991

Mason, Malcolm David 2011. Re: Predictors of androgen deprivation therapy efficacy combined with prostatic irradiation: the central role of tumor stage and radiation dose, Williams S, Buyyounouski M, Kestin L, Duchesne G, Pickles T: Int J Radiat Oncol Biol Phys 2011;79:724–31 [Reply]. European Urology 60 (1) , pp. 179-180. 10.1016/j.eururo.2011.04.017

Sonpavde, Guru, Attard, Gerhardt, Bellmunt, Joaquim, Mason, Malcolm David, Malavaud, Bernard, Tombal, Bertrand and Sternberg, Cora N. 2011. The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literature. European Urology 60 (2) , pp. 270-278. 10.1016/j.eururo.2011.04.032

Mottet, Nicolas, Bellmunt, Joaquim, Bolla, Michel, Joniau, Steven, Mason, Malcolm David, Matveev, Vsevolod, Schmid, Hans-Peter, Van der Kwast, Theo, Wiegel, Thomas, Zattoni, Filiberto and Heidenreich, Axel 2011. Reply to Stefano Fanti, Bernd Krause, Wolfgang Weber, et al's Letter to the Editor re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 2011;59:572-83 [Letter]. European Urology 60 (5) , e39-e41. 10.1016/j.eururo.2011.08.010

Shelley, Michael D., Cleves, Anne, Wilt, Timothy J. and Mason, Malcolm David 2011. Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma. BJU International 108 (2) , pp. 168-179. 10.1111/j.1464-410X.2011.10341.x

Ablin, Richard J, Kynaston, Howard, Mason, Malcolm David and Jiang, Wen Guo 2011. Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer. Journal of Translational Medicine 9 , pp. 49-57. 10.1186/1479-5876-9-49

Martin, Tracey Amanda, Mason, Malcolm David and Jiang, Wen Guo 2011. Tight junctions in cancer metastasis. Frontiers in Bioscience 16 (3) , pp. 898-936. 10.2741/3726

Payne, H. and Mason, Malcolm David 2011. Androgen deprivation therapy as adjuvant/neoadjuvant to radiotherapy for high-risk localised and locally advanced prostate cancer: recent developments. British Journal of Cancer 105 (11) , pp. 1628-1634. 10.1038/bjc.2011.385

Webber, Jason P., Steadman, Robert, Mason, Malcolm David, Tabi, Zsuzsanna and Clayton, Aled 2010. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Research 70 (23) , pp. 9621-9630. 10.1158/0008-5472.CAN-10-1722

Sanders, Andrew James, Ye, Lin, Mason, Malcolm David and Jiang, Wen Guo 2010. The impact of EPLIN alpha (Epithelial protein lost in neoplasm) on endothelial cells, angiogenesis and tumorigenesis. Angiogenesis 13 (4) , pp. 317-326.

Sanders, Andrew James, Ye, Lin, Mason, Malcolm David and Jiang, Wen Guo 2010. The impact of EPLINα (Epithelial protein lost in neoplasm) on endothelial cells, angiogenesis and tumorigenesis. Angiogenesis 13 (4) , pp. 317-326. 10.1007/s10456-010-9188-7

Tabi, Zsuzsanna, Spary, Lisa Kate, Coleman, Sharon Louise, Clayton, Aled, Mason, Malcolm David and Staffurth, John Nicholas 2010. Resistance of CD45RA- T cells to apoptosis and functional impairment, and activation of tumor-antigen specific T cells during radiation therapy of prostate cancer. The Journal of Immunology 185 (2) , pp. 1330-1339. 10.4049/jimmunol.1000488

Welton, Joanne L., Khanna, Sanjay, Giles, Peter James, Brennan, Paul, Brewis, Ian Andrew, Staffurth, John Nicholas, Mason, Malcolm David and Clayton, Aled 2010. Proteomics analysis of bladder cancer exosomes. Molecular & Cellular Proteomics 9 (6) , pp. 1324-1338. 10.1074/mcp.M000063-MCP201

Shelley, Mike D., Mason, Malcolm David and Kynaston, Howard 2010. Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses. Cancer Treatment Reviews 36 (3) , pp. 195-205. 10.1016/j.ctrv.2009.12.005

Sanders, Andrew James, Guo, Xiaoxia, Mason, Malcolm David and Jiang, Wen Guo 2010. IL-17B can impact on endothelial cellular traits linked to tumour angiogenesis. Journal of Oncology 2010 , 817375. 10.1155/2010/817375

Lane, Jane, Martin, Tracey, McGuigan, Christopher, Mason, Malcolm and Jiang, Wen 2010. The differential expression of hCNT1 and hENT1 i n breast cancer and the possible impact on breast cancer therapy. Journal of Experimental Therapeutics and Oncology 8 (3) , pp. 203-210.

Sanders, Andrew James, Webb, Siobhan L., Parr, Christian, Mason, Malcolm David and Jiang, Wen Guo 2010. The type II transmembrane serine protease, matriptase-2: possible links to cancer ? Anti-Cancer Agents in Medicinal Chemistry 10 (1) , pp. 64-69.

Jiang, Wen Guo, Ye, Lin, Ablin, Richard J., Kynaston, Howard and Mason, Malcolm David 2010. The prostate transglutaminase, TGase-4, coordinates with the HGFL/MSP-RON system in stimulating the migration of prostate cancer cells. International Journal of Oncology 37 (2) , pp. 413-418. 10.3892/ijo_00000689

Mason, Malcolm David and Moffat, Leslie 2010. Prostate cancer. 2nd ed. The facts, Oxford: Oxford University Press.

Lewison, Grant, Purushotham, Arnie, Mason, Malcolm David, McVie, Gordon and Sullivan, Richard 2010. Understanding the impact of public policy on cancer research: A bibliometric approach. European Journal of Cancer 46 (5) , pp. 912-919. 10.1016/j.ejca.2009.12.020

de la Rosette, J., Ahmed, H., Barentsz, J., Johansen, T. Bjerklund, Brausi, M., Emberton, M., Frauscher, F., Greene, D., Harisinghani, M., Haustermans, K., Heidenreich, A., Kovacs, G., Mason, Malcolm David, Montironi, R., Mouraviev, V., de Reijke, T., Taneja, S., Thuroff, S., Tombal, B., Trachtenberg, J., Wijkstra, H. and Polascik, T. 2010. Focal therapy in prostate cancer - report from a consensus panel. Journal of Endourology 24 (5) , pp. 775-780. 10.1089/end.2009.0596

Taneja, Samir S. and Mason, Malcolm David 2010. Candidate Selection for Prostate Cancer Focal Therapy. Journal of Endourology 24 (5) , pp. 835-841. 10.1089/end.2010.0006

Dearnaley, David P., Mason, Malcolm David, Parmar, Mahesh K. B., Sanders, Karen and Sydes, Matthew R. 2009. Adjuvant therapy with oral sodium clodronate in locally advanced and metastatic prostate cancer: Long-term overall survival results from the MRC PR04 and PR05 randomised controlled trials. The Lancet Oncology 10 (9) , pp. 872-876. 10.1016/S1470-2045(09)70201-3

Courtier, Nicholas, Gambling, Tina and Mason, Malcolm David 2009. Fatigue, depression and physical activity in breast radiotherapy patients: Are they explained by sickness behaviour? [Abstract]. Clinical Oncology 21 (3) , p. 251. 10.1016/j.clon.2009.01.001

Jones, C. E., Mason, Malcolm David, Brown, Paul, Staffurth, John Nicholas and Smith, C. 2009. The development and introduction of a written post-radiotherapy information leaflet for prostate cancer patients [Abstract]. Clinical Oncology 21 (3) , p. 270. 10.1016/j.clon.2009.01.001

Shelley, M. D., Kumar, S., Wilt, T., Staffurth, John Nicholas, Coles, Bernadette Mary and Mason, Malcolm David 2009. A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma. Cancer Treatment Reviews 35 (1) , pp. 9-17. 10.1016/j.ctrv.2008.08.002

Mitchell, Philip J., Welton, Joanne L., Staffurth, John Nicholas, Court, Jacquelyn, Mason, Malcolm David, Tabi, Zsuzsanna and Clayton, Aled 2009. Can urinary exosomes act as treatment response markers in prostate cancer? Journal Of Translational Medicine 7 (4) , n/a. 10.1186/1479-5876-7-4

Navabi, Hossein, Jasani, Bharat, Reece, Ann, Clayton, Aled, Tabi, Zsuzsanna, Donninger, C., Mason, Malcolm David and Adams, Malcolm 2009. A clinical grade poly I:C-analogue (Ampligen®) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro. Vaccine 27 (1) , pp. 107-115. 10.1016/j.vaccine.2008.10.024

Clayton, Aled and Mason, Malcolm David 2009. Exosomes in tumour immunity. Current Oncology -Toronto- 16 (3) , pp. 46-49.

Jiang, Wen Guo, Ablin, Richard J., Kynaston, Howard and Mason, Malcolm David 2009. The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway. Microvascular Research 77 (2) , pp. 150-157. 10.1016/j.mvr.2008.09.010

James, Nicholas D., Sydes, Matthew R., Clarke, Noel W., Mason, Malcolm David, Dearnaley, David P., Anderson, John, Popert, Richard J., Sanders, Karen, Morgan, Rachel C., Stansfeld, Jim, Dwyer, John, Masters, John and Parmar, Mahesh K.B. 2009. Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial. BJU International 103 (4) , pp. 464-469. 10.1111/j.1464-410X.2008.08034.x

Shelley, M. D., Kumar, S., Coles, Bernadette Mary, Wilt, T., Staffurth, John Nicholas and Mason, Malcolm David 2009. Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: a systematic review and meta-analysis of randomised trials. Cancer Treatment Reviews 35 (7) , pp. 540-546. 10.1016/j.ctrv.2009.05.001

Harnden, Patricia, Shelley, Michael D., Naylor, Brian, Coles, Bernadette and Mason, Malcolm David 2008. Does the Extent of Carcinoma in Prostatic Biopsies Predict Prostate-Specific Antigen Recurrence? A Systematic Review. European Urology 54 (4) , pp. 728-739. 10.1016/j.eururo.2008.06.068

Sanders, Andrew James, Parr, Christian, Martin, Tracey Amanda, Lane, Jane, Mason, Malcolm David and Jiang, Wen Guo 2008. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation. Journal of Cellular Physiology 216 (3) , pp. 780-789. 10.1002/jcp.21460

Clayton, Aled, Mitchell, John Paul, Court, Jacquelyn, Linnane, Seamus, Mason, Malcolm David and Tabi, Zsuzsanna 2008. Human tumor-derived exosomes down-modulate NKG2D expression. Journal of Immunology 180 (11) , pp. 7249-7258.

Harnden, Patricia, Naylor, Brian, Shelley, Michael D., Clements, Hayley, Coles, Bernadette Mary and Mason, Malcolm David 2008. The clinical management of patients with a small volume of prostatic cancer on biopsy: what are the risks of progression? Cancer 112 (5) , pp. 971-981. 10.1002/cncr.23277

Krege, Susanne, Beyer, Jörg, Souchon, Rainer, Albers, Peter, Albrecht, Walter, Algaba, Ferran, Bamberg, Michael, Bodrogi, István, Bokemeyer, Carsten, CavallinStåhl, Eva, Classen, Johannes, Clemm, Christoph, Cohn-Cedermark, Gabriella, Culine, Stéphane, Daugaard, Gedske, De Mulder, Pieter H.M., De Santis, Maria, de Wit, Maike, de Wit, Ronald, Derigs, Hans Günter, Dieckmann, Klaus-Peter, Dieing, Annette, Droz, Jean-Pierre, Fenner, Martin, Fizazi, Karim, Flechon, Aude, Fosså, Sophie D., Garcia del Muro, Xavier, Gauler, Thomas, Geczi, Lajos, Gerl, Arthur, Germa-Lluch, Jose Ramon, Gillessen, Silke, Hartmann, Jörg T., Hartmann, Michael, Heidenreich, Axel, Hoeltl, Wolfgang, Horwich, Alan, Huddart, Robert, Jewett, Michael, Joffe, Johnathan, Jones, William G., Kisbenedek, László, Klepp, Olbjørn, Kliesch, Sabine, Koehrmann, Kai Uwe, Kollmannsberger, Christian, Kuczyk, Markus, Laguna, Pilar, Leiva Galvis, Oscar, Loy, Volker, Mason, Malcolm David, Mead, Graham M., Mueller, Rolf, Nichols, Craig, Nicolai, Nicola, Oliver, Tim, Ondrus, Dalibor, Oosterhof, Gosse O.N., Paz Ares, Luis, Pizzocaro, Giorgio, Pont, Jörg, Pottek, Tobias, Powles, Tom, Rick, Oliver, Rosti, Giovanni, Salvioni, Roberto, Scheiderbauer, Jutta, Schmelz, Hans-Ulrich, Schmidberger, Heinz, Schmoll, Hans-Joachim, Schrader, Mark, Sedlmayer, Felix, Skakkebaek, Niels E., Sohaib, Aslam, Tjulandin, Sergei, Warde, Padraig, Weinknecht, Stefan, Weissbach, Lothar, Wittekind, Christian, Winter, Eva, Wood, Lori and von der Maase, Hans 2008. European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I. European Urology 53 (3) , pp. 478-496. 10.1016/j.eururo.2007.12.024

Hudson, E., Kynaston, Howard, Varma, Muralidharan, Carter, A., Staffurth, John Nicholas, Barber, Jim, Mason, Malcolm David and Lester, Jason Francis 2008. Radiotherapy after radical prostatectomy for adenocarcinoma of the prostate: a UK institutional experience and review of published studies. Clinical Oncology 20 (5) , pp. 353-357. 10.1016/j.clon.2008.02.008

Clarke, N. W., Sydes, M. R., Dearnaley, D., Mason, Malcolm David, Morgan, R. C., Sanders, K., Anderson, J., Popert, R., Masters, J., Parmar, M. and James, N. D. 2008. Results of the feasibility stage of stampede: a multiarm, multi-stage phase II/III trial for patients with high risk prostate cancer (ISRCTN78818544) [Abstract]. European Urology Supplements 7 (3) , p. 233. 10.1016/S1569-9056(08)60648-X

Coleman, Sharon Louise, Gibbs, Allen, Butchart, Eric, Mason, Malcolm David, Jasani, Bharat and Tabi, Zsuzsanna 2008. SV40 large T antigen-specific human T cell memory responses. Journal of Medical Virology 80 (8) , pp. 1497-1504. 10.1002/jmv.21216

James, N. D., Sydes, M. R., Clarke, N. W., Mason, Malcolm David, Dearnaley, D. P., Anderson, J., Popert, R. J., Sanders, K., Morgan, R. C., Stansfeld, J., Dwyer, J., Masters, J. and Parmar, M. K. B. 2008. STAMPEDE: systemic therapy for advancing or metastatic prostate cancer - a multi-arm multi-stage randomised controlled trial [Editorial]. Clinical Oncology 20 (8) , pp. 577-581. 10.1016/j.clon.2008.07.002

Ablin, Richard J. and Mason, Malcolm David, eds. 2008. Metastasis of prostate cancer. Cancer metastasis - biology and treatment, vol. 10. Dordrecht: Springer.

Davies, Gaynor, Martin, Tracey Amanda, Ye, Lin, Lewis-Russell, Jonathon M., Mason, Malcolm David and Jiang, Wen Guo 2008. Phospholipase-C gamma-1 (PLCγ-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells. Urologic Oncology: Seminars and Original Investigations 26 (4) , pp. 386-391. 10.1016/j.urolonc.2007.06.003

Staffurth, John Nicholas and Mason, Malcolm David 2008. Radiotherapy for early prostate cancer. In: Kirk, David ed. International handbook of prostate cancer. 3rd ed, Hampshire: Euromed Communications Limited, pp. 161-182.

Davies, Gaynor, Jiang, Wen Guo and Mason, Malcolm David 2008. Hepatocyte growth factor/scatter factor and prostate cancer metastasis. In: Ablin, Richard J. and Mason, Malcolm David eds. Metastasis of prostate cancer, Cancer Metastasis, vol. 10. Dordrecht: Springer, pp. 197-220.

Mitchell, John Paul, Court, Jacqueline, Mason, Malcolm David, Tabi, Zsuzsanna and Clayton, Aled 2008. Increased exosome production from tumour cell cultures using the Integra CELLine Culture System. Journal of Immunological Methods 335 (1-2) , pp. 98-105. 10.1016/j.jim.2008.03.001

Krege, Susanne, Beyer, Jörg, Souchon, Rainer, Albers, Peter, Albrecht, Walter, Algaba, Ferran, Bamberg, Michael, Bodrogi, István, Bokemeyer, Carsten, Cavallin-Ståhl, Eva, Classen, Johannes, Clemm, Christoph, Cohn-Cedermark, Gabriella, Culine, Stéphane, Daugaard, Gedske, De Mulder, Pieter H. M., De Santis, Maria, de Wit, Maike, de Wit, Ronald, Derigs, Hans Günter, Dieckmann, Klaus-Peter, Dieing, Annette, Droz, Jean-Pierre, Fenner, Martin, Fizazi, Karim, Flechon, Aude, Fosså, Sophie D., Garcia del Muro, Xavier, Gauler, Thomas, Geczi, Lajos, Gerl, Arthur, Germa-Lluch, Jose Ramon, Gillessen, Silke, Hartmann, Jörg T., Hartmann, Michael, Heidenreich, Axel, Hoeltl, Wolfgang, Horwich, Alan, Huddart, Robert, Jewett, Michael, Joffe, Johnathan, Jones, William G., Kisbenedek, László, Klepp, Olbjørn, Kliesch, Sabine, Koehrmann, Kai Uwe, Kollmannsberger, Christian, Kuczyk, Markus, Laguna, Pilar, Leiva Galvis, Oscar, Loy, Volker, Mason, Malcolm David, Mead, Graham M., Mueller, Rolf, Nichols, Craig, Nicolai, Nicola, Oliver, Tim, Ondrus, Dalibor, Oosterhof, Gosse O.N., Paz-Ares, Luis, Pizzocaro, Giorgio, Pont, Jörg, Pottek, Tobias, Powles, Tom, Rick, Oliver, Rosti, Giovanni, Salvioni, Roberto, Scheiderbauer, Jutta, Schmelz, Hans-Ulrich, Schmidberger, Heinz, Schmoll, Hans-Joachim, Schrader, Mark, Sedlmayer, Felix, Skakkebaek, Niels E., Sohaib, Aslam, Tjulandin, Sergei, Warde, Padraig, Weinknecht, Stefan, Weissbach, Lothar, Wittekind, Christian, Winter, Eva, Wood, Lori and von der Maase, Hans 2008. European Consensus Conference on Diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II. European Urology 53 (3) , pp. 497-513. 10.1016/j.eururo.2007.12.025

Courtier, Nicholas, Gambling, Tina and Mason, Malcolm David 2008. Joy in repetition: the effect of advances in statistical software on the analysis of repeated measures studies in radiotherapy research. Presented at: Society & College of Radiographers Radiotherapy Conference, Brighton, 2 February 2008.

Courtier, Nicholas, Gambling, Tina and Mason, Malcolm David 2008. Acute fatigue in a breast radiotherapy cohort and its relationship to irradiated volumes, body mass index and biological factors. Presented at: National Cancer Research Institute (NCRI) Cancer Conference, Birmingham, UK, 5-8 October 2008.

Sanders, Andrew James, Parr, Christian, Mason, Malcolm David and Jiang, Wen Guo 2007. Suppression of hepatocyte growth factor activator inhibitor-1 leads to a more aggressive phenotype of prostate cancer cells in vitro. International Journal of Molecular Medicine 20 (4) , pp. 613-619.

Parr, Christian, Sanders, Andrew, Davies, Gaynor, Martin, Tracey, Lane, Jane, Mason, Malcolm, Mansel, Robert and Jiang, Wen 2007. Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients. Clinical Cancer Research 13 (12) , pp. 3568-3576. 10.1158/1078-0432.CCR-06-2357

Mason, Malcolm David, Glaholm, J., Sydes, M. R. and Matthew, R. 2007. Oral sodium clodronate for non-metastatic prostate cancer - results of a randomized double-blind, placebo-controlled trial: MRC PR04 (ISRCTN61384873). Journal of the National Cancer Institute 99 (10) , pp. 765-776. 10.1093/jnci/djk178

Harnden, P., Shelley, M. D., Coles, Bernadette Mary, Staffurth, John Nicholas and Mason, Malcolm David 2007. Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis. The Lancet Oncology 8 (5) , pp. 411-419. 10.1016/S1470-2045(07)70136-5

Clayton, Aled, Mason, Malcolm David, Mitchell, John Paul and Tabi, Zsuzsanna 2007. Human tumour-derived exosomes selectively impair lymphocyte responses to Interleukin-2. Cancer Research 67 , pp. 7458-7466. 10.1158/0008-5472.CAN-06-3456

Jiang, Wen Guo, Davies, Gaynor, Martin, Tracey A., Kynaston, Howard, Mason, Malcolm David and Fodstad, Oystein 2006. Com-1/p8 acts as a putative tumour suppressor in prostate cancer. International Journal of Molecular Medicine 18 (5) , pp. 981-986.

Harrison, G.M., Davies, G., Martin, Tracey Amanda, Mason, Malcolm David and Jiang, Wen Guo 2006. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells. Oncology Reports 15 (1) , pp. 199-206. 10.3892/or.15.1.199

Sanders, Andrew James, Parr, Christian, Davies, Gaynor, Martin, Tracey Amanda, Lane, Jane, Mason, Malcolm David and Jiang, Wen Guo 2006. Genetic reduction of matriptase-1 expressionj is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. Journal of Experimental Therapeautics and Oncology 6 (1) , pp. 39-48.

Sanders, Andrew James, Parr, Christian, Davies, Gaynor, Martin, Tracey Amanda, Lane, Jane, Mason, Malcolm David and Jiang, Wen Guo 2006. Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. Journal of Experimental Therapeutics and Oncology 6 (1) , pp. 39-48.

Jiang, Wen Guo, Davies, G., Ye, Lin, Russell-Lewis, J., Mason, Malcolm David and Mansel, Robert Edward 2006. EPLIN (epithelial protein lost in neoplasm) affects matrix adhesion and cellular motility of breast cancer cells, the role of ezrin [Abstract]. Breast Cancer Research and Treatment 100 , S161-S161.

Congiatu, Costantino, Brancale, Andrea, Mason, Malcolm David, Jiang, Wen Guo and McGuigan, Christopher 2006. Novel potential anticancer naphthyl phosphoramidates of BVdU: Separation of diastereoisomers and assignment of the absolute cConfiguration of the phosphorus center. Journal of Medicinal Chemistry 49 (2) , pp. 452-455. 10.1021/jm0509896

Jiang, Wen Guo, Davies, Gaynor, Martin, Tracey Amanda, Parr, Christian, Watkins, Gareth, Mason, Malcolm David, Mokbel, Kefah and Mansel, Robert Edward 2005. Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy. Clinical Cancer Research 11 (16) , pp. 6012-6019. 10.1158/1078-0432.CCR-05-0275

Clayton, Aled, Turkes, Atilla, Mason, M. D. and Tabi, Zsuzsanna 2005. Induction of heat shock proteins in B-cell exosomes. Journal of Cell Science 118 (16) , pp. 3631-3638. 10.1242/jcs.02494

Coleman, Sharon Louise, Clayton, Aled, Mason, Malcolm David, Jasani, Bharat, Adams, Malcolm and Tabi, Zsuzsanna 2005. Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer. Cancer Research 65 (15) , pp. 7000-7006. 10.1158/0008-5472.CAN-04-3792

Coleman, Sharon Louise, Clayton, Aled, Mason, Malcolm David, Jasani, Bharat, Adams, Malcolm and Tabi, Zsuzsanna 2005. Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer. Cancer Research 65 (15) , pp. 7000-6. 10.1158/0008-5472.CAN-04-3792

Oliver, R. T. D., Mason, Malcolm David, Mead, G. M., Maase, H. von der, Rustin, G. J. S ., Joffe, J. K ., Wit, R. de, Aass, N., Graham, J. D ., Coleman, R., Kirk, S. J . and Stenning, S. P. 2005. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. The lancet 366 , pp. 293-300. 10.1016/S0140-6736(05)66984-X

Adams, M., Navabi, H., Croston, D., Coleman, Sharon Louise, Tabi, Zsuzsanna, Clayton, Aled, Jasani, Bharat and Mason, Malcolm David 2005. The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer. Vaccine 23 (17-18) , pp. 2374-2378. 10.1016/j.vaccine.2005.01.014

Navabi, H., Croston, D., Hobot, Jan, Clayton, Aled, Zitvogel, L., Jasani, Bharat, Bailey-Wood, R., Wilson, Keith, Tabi, Zsuzsanna, Mason, Malcolm and Adams, M. 2005. Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial. Blood Cells, Molecules, and Diseases 35 (2) , pp. 149-152. 10.1016/j.bcmd.2005.06.008

Jasani, Bharat, Coleman, Sharon Louise, Butchart, Eric, Evans, Eve M.L., Adams, Malcolm, Mason, Malcolm David, Gibbs, Allen and Tabi, Zsuzsanna 2005. Assessment of immunological competence and SV40 specific recall immunity in malignant pleural mesothelioma. Vaccine 23 (17-18) , pp. 2339-2402. 10.1016/j.vaccine.2005.01.019

Jiang, Wen, Davies, G., Martin, Tracey Amanda, Parr, C., Mason, Malcolm David and Mansel, Robert Edward 2005. Manipulation of expression of MMP-14 and its impact on the invasivess and progression of breast cancer cells [Abstract]. Breast Cancer Research and Treatment 94 , S187-S187.

Clayton, Aled, Turkes, Atilla, Dewitt, Sharon, Steadman, Robert, Mason, Malcolm David and Hallett, Maurice Bartlett 2004. Adhesion and signaling by B cell-derived exosomes: the role of integrins. The FASEB Journal 18 , pp. 977-979. 10.1096/fj.03-1094fje

Morris-Stiff, G., Steel, A., Savage, P., Devlin, J., Griffiths, David, Portman, B., Mason, Malcolm David and Jurewicz, W. A. 2004. Transmission of donor melanoma to multiple organ transplant recipients. American Journal of Transplantation 4 (3) , pp. 444-446. 10.1111/j.1600-6143.2004.00335.x

Dearnaley, David P., Sydes, Matthew R., Mason, Malcolm David, Stott, Mark, Powell, Christopher S., Robinson, Anne C. R., Thompson, Peter M., Moffat, Leslie E., Naylor, Sharon L. and Parmar, Mahesh K. B. 2003. A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial). J Natl Cancer Inst 95 (17) , pp. 1300-11. 10.1093/jnci/djg038

Davies, Gaynor, Mason, Malcolm David, Martin, Tracey Amanda, Parr, Christian, Watkins, Gareth, Lane, Jane, Jiang, Wen Guo, Matsumoto, Kunio and Nakamura, Toshikazu 2003. The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesisin vivo. International Journal of Cancer 106 (3) , pp. 348-354. 10.1002/ijc.11220

Al-Mohammadi, A, Salek, Mir-saeed, Maughan, Timothy Stanley, Nicholls, P. J. and Mason, Malcolm David 2003. The impact of routine assessment of information needs on patient outcomes. Psycho-oncology 12 (6) , p. 641. 10.1002/pon.752

Christian, J. A., Huddart, R. A., Norman, A., Mason, Malcolm David, Fossa, S., Aass, N., Nicholl, E. J., Dearnaley, David P. and Horwich, A. 2003. Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors. Journal of Clinical Oncology 21 (5) , pp. 871-877. 10.1200/JCO.2003.05.155

Clayton, Aled, Harris, Claire Louise, Morgan, Bryan Paul and Mason, Malcolm David 2003. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. European Journal of Immunology 33 (2) , pp. 522-31. 10.1002/immu.200310028

Mason, Malcolm David and Shelley, Mike 2003. Cancer of the prostate. In: Williams, C. B., Bramwell, V., Bonfill, X., Cuzik, J., Grant, R., Guthrie, D., Mason, Malcolm David, Simmonds, P., Singh, A. D., Weston, R. and Williams, H. C. eds. Evidence-Based Oncology, London: BMJ Books, pp. 354-359. (10.1002/9780470987360.ch32)

Shelley, Mike, Burgon, Kathryn and Mason, Malcolm David 2003. Can lifestyle behaviour change reduce the risk and incidence of urological cancers? In: Williams, C. B., Bramwell, V., Bonfill, X., Cuzik, J., Grant, R., Guthrie, D., Mason, Malcolm David, Simmonds, P., Singh, A. D., Weston, R. and Williams, H. C. eds. Evidence-Based Oncology, London: BMJ Books, pp. 87-100. (10.1002/9780470987360.ch11)

Shelley, Mike, Oliver, Tim and Mason, Malcolm David 2003. Testicular germ cell cancer. In: Williams, C. B., Bramwell, V., Bonfill, X., Cuzik, J., Grant, R., Guthrie, D., Mason, Malcolm David, Simmonds, P., Singh, A. D., Weston, R. and Williams, H. C. eds. Evidence-Based Oncology, London: BMJ Books, pp. 365-373. (10.1002/9780470987360.ch34)

Shelley, Mike and Mason, Malcolm David 2003. Cancer of the penis. In: Williams, C. B., Bramwell, V., Bonfill, X., Cuzik, J., Grant, R., Guthrie, D., Mason, Malcolm David, Simmonds, P., Singh, A. D., Weston, R. and Williams, H. C. eds. Evidence-Based Oncology, London: BMJ Books, pp. 360-364. (10.1002/9780470987360.ch33)

Bisson, Jonathan Ian, Chubb, H. L., Bennett, S., Mason, Malcolm David, Jones, D. and Kynaston, Howard Gordon 2002. The prevalence and predictors of psychological distress in patients with early localized prostate cancer. British Journal of Urology International 90 (1) , pp. 56-61. 10.1046/j.1464-410X.2002.02806.x

Parr, Christian, Davies, G., Nakamura, T., Matsumoto, Kei, Mason, Malcolm David and Jiang, Wen Guo 2001. The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant. Biochemical and Biophysical Research Communications 285 (5) , pp. 1330-1337. 10.1006/bbrc.2001.5307

Davies, G., Jiang, Wen Guo and Mason, Malcolm David 2001. HGF/SF modifies the interaction between its receptor c-Met, and the E-cadherin/catenin complex in prostate cancer cells. International Journal of Molecular Medicine 7 , pp. 385-388. 10.3892/ijmm.7.4.385

Davies, G., Jiang, Wen Guo and Mason, Malcolm David 2001. The interaction between beta-catenin, GSK3beta and APC after motogen induced cell-cell dissociation, and their involvement in signal transduction pathways in prostate cancer. International Journal of Oncology 18 (4) , pp. 843-847. 10.3892/ijo.18.4.843

Adams, Malcolm, Borysiewicz, Leszek K., Fiander, Alison Nina, Man, Stephen Tzekwung, Jasani, Bharat, Navabi, Hossein, Lipetz, C., Evans, A. S. and Mason, Malcolm David 2001. Clinical studies of human papilloma vaccines in pre-invasive and invasive cancer. Vaccine 19 (17-19) , pp. 2549-2556. 10.1016/S0264-410X(00)00488-6

Clayton, Aled, Court, Jacquelyn, Navabi, Hossein, Adams, Malcolm, Mason, Malcolm David, Hobot, Jan Adam, Newman, Geoff R. and Jasani, Bharat 2001. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. Journal of Immunological Methods 247 (1-2) , pp. 163-174. 10.1016/S0022-1759(00)00321-5

Mason, Malcolm David, Brewster, S., Moffat, L. E., Kirkbride, P., Cowan, Rona, Malone, P., Sydes, M. and Parmer, M. K. B. 2000. Randomized trials in early prostate cancer. II: Hormone therapy and radiotherapy for locally advanced disease: A question is still unanswered. Clinical Oncology 12 (4) , pp. 215-216. 10.1053/clon.2000.9156

Davies, G., Jiang, Wen Guo and Mason, Malcolm David 2000. Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells. Journal of Urology 163 (3) , pp. 985-992.

Davies, G., Jiang, Wen Guo and Mason, Malcolm David 1999. Cell-cell adhesion molecules and their associated proteins in bladder cancer cells and their role in mitogen induced cell-cell dissociation and invasion. Anticancer Research 19 (1A) , pp. 547-552.

Davies, G., Hiscox, Stephen Edward, Llaffafian, I., Jiang, Wen Guo and Mason, Malcolm D. 1999. HGF/SF influences the interaction between APC, GSK3 beta and beta-catenin, its impact on cell adhesion and in vitro invasion in prostate cancer. British Journal of Cancer 80 (Supp 2) , p. 36.